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Resumen 
El crecimiento del feto depende, en gran medida, de un óptimo estado nutricional materno y un 
correcto desarrollo placentario, siendo estos dos factores agentes limitantes de su potencial 
genético. Una pauta alimentaria incorrecta o deficiente durante la gestación puede predisponer al 
desarrollo de ciertas complicaciones médicas a corto y/o largo plazo, tanto en la madre como en 
su descendencia. 
Entre las complicaciones fetales que aparecen con más frecuencia destaca el llamado 
Crecimiento Intrauterino Retardado (CIR), que se basa en una reducción del desarrollo fetal 
dando lugar a individuos con bajo peso y con alteraciones funcionales y/o en el tamaño de sus 
órganos al nacimiento. Esta desproporción suele estar asociada a cambios en determinados 
órganos, como el cerebro, hígado o páncreas, que pueden predisponerles a desarrollar ciertas 
enfermedades en edad adulta. La etiología del CIR es multifactorial, si bien la nutrición materna 
juega un papel fundamental. Pautas alimentarias incorrectas durante la gestación, tales como la 
alteración en los componentes de la dieta o la restricción de determinados nutrientes pueden 
afectar la funcionalidad de la placenta y, por tanto, la cantidad de alimento y oxígeno que llegan 
al feto en desarrollo. En el caso de la restricción alimentaria, estos posibles cambios 
dependerán, en gran medida, de la intensidad, del periodo de exposición y del tipo de restricción.  
Las limitaciones tanto éticas como prácticas que conlleva la realización de estudios 
intervencionales en medicina humana determinan el empleo de modelos animales. De hecho, 
gran parte del avance obtenido en el conocimiento sobre las complicaciones gestacionales y sus 
posibles consecuencias en el desarrollo fetal y placentario se ha obtenido a través del uso de 
animales de experimentación; principalmente, de roedores y ovinos. Sin embargo, existen otros 
modelos animales como la coneja, que son válidos para el estudio de la insuficiencia placentaria 
y/o CIR, ya que presentan, entre otras ventajas, una placentación de tipo hemocorial y un 
desarrollo de determinados órganos fetales, como el cerebro, que presenta similitudes con la 
especie humana.  
Además, el conejo se explota con fines productivos en los países mediterráneos, por lo que tiene 
una doble funcionalidad, como modelo biomédico y animal de producción. Por consiguiente, los 
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resultados obtenidos en pruebas experimentales realizadas en la coneja, como aquellas basadas 
en la reducción del aporte nutricional a la madre gestante, además de permitir estudiar las 
consecuencias sobre la función placentaria y el desarrollo fetal, permiten avanzar en el 
conocimiento sobre los posibles efectos que tiene la aplicación de dichas pautas en las granjas 
cunícolas. En este sentido, la reducción del coste en alimentación puede significar un beneficio 
económico muy importante para el ganadero debido a que la alimentación supera el 60% de los 
costes de producción. Por ello, la restricción alimentaria o ajustar el consumo a las necesidades 
fisiológicas de la reproductora, podría ser una estrategia de manejo a estudiar, ya que implicaría 
un ahorro económico para el cunicultor. Este manejo podría aplicarse especialmente en aquellos 
casos en los que la hembra se encuentra en las primeras etapas de la gestación y sus 
necesidades metabólicas o energéticas todavía no son máximas. 
Así pues, el objetivo general de la presente Tesis Doctoral ha sido estudiar, en la coneja, los 
posibles efectos que genera la aplicación de pautas de restricción alimentaria gestacionales 
(RAG) del 50% en distintos momentos de la gestación a nivel materno, fetoplacentario y 
neonatal. Específicamente se han evaluado: 1) los cambios hemodinámicos sufridos a nivel 
placentario y fetal, así como la morfometría de la descendencia antes y después del nacimiento, 
2) los efectos de un tratamiento vasodilatador a base de Citrato de Sildenafilo y 3) las 
consecuencias en el perfil metabólico de la madre, en la estructura histológica de la placenta y 
en la biometría fetal dependiendo de la fase de la gestación en la que la RAG es aplicada.  
En el primer experimento de la Tesis Doctoral se evaluó el efecto que tiene la aplicación de la 
RAG al 50% una vez el embrión ya está implantado y comienza la formación de la placenta (día 
9) hasta el final de la gestación (día 31). En este trabajo se evaluaron los cambios 
hemodinámicos placentarios (arteria umbilical; UCA) y fetales (arteria cerebral media; MCA), así 
como la morfometría fetal al final del segundo tercio de gestación. Posteriormente, en el 
momento del parto, se valoraron las consecuencias de la RAG sobre el peso corporal materno y 
el desarrollo de su descendencia, así como las tasas de mortalidad neonatal. La viabilidad y 
fiabilidad de la técnica ecográfica y del examen Doppler como métodos no invasivos para la 
detección precoz de los cambios en los patrones de crecimiento y hemodinámica fetales en esta 
especie quedaron confirmadas. Los fetos expuestos a RAG evidenciaron menores velocidades 
diastólicas y mayores velocidades sistólicas a nivel de la UCA que los controles, aumentando la 
velocidad media en esta arteria, que tendió a presentar mayores índices de pulsatilidad y de 
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resistencia. Estas alteraciones fueron debidas posiblemente a un deterioro en la funcionalidad 
placentaria por isquemia, que secundariamente generó también reducciones en la biometría 
fetal. No obstante, la RAG no afectó al peso corporal de la hembra y tampoco se observó una 
mayor mortalidad neonatal respecto al grupo alimentado ad libitum, a pesar del reducido tamaño 
de los recién nacidos. 
En el segundo experimento de esta Tesis Doctoral se abundó en el estudio previo utilizándose el 
mismo periodo e intensidad de RAG, pero añadiéndose un grupo experimental tratado con 
Citrato de Sildenafilo (SC) en el último tercio de gestación. Los datos de las conejas sometidas a 
RAG obtenidos a día 26-28 de gestación reforzaron los resultados del desarrollo placentario y 
fetal determinados previamente. A nivel histológico las placentas del grupo restringido mostraron 
una decidua más delgada y un incremento del tejido conjuntivo fibroso desde la zona de unión 
hacia el laberinto que reemplazaba la superficie vascularizada en esa área. El tamaño y el peso 
de los fetos disminuyeron significativamente. La administración de SC generó cambios en el 
tamaño de la placenta y mejoró la vascularización, principalmente en la zona del laberinto y de la 
decidua, pudiendo contrarrestar parcialmente los efectos adversos de dicha RAG, compensando 
la biometría de los fetos y de los neonatos, aunque no mejoró significativamente el peso del 
individuo. Sin embargo, algunos datos referentes a la funcionalidad cerebral y hepática del feto 
sugirieron un posible aumento en el flujo cerebral del feto y una vasoconstricción compensatoria 
cuyas consecuencias en la descendencia a corto y largo plazo necesitan de más estudios.   
En el tercer experimento, se compararon los efectos de la RAG al 50% aplicada en el periodo 
preimplantacional (día 0 a día 7 de gestación) y durante toda la gestación (día 0 a día 31 de 
gestación) frente a una alimentación ad libitum, complementando así el estudio anterior. En 
ambos periodos, la RAG no indujo cambios macroscópicos en el peso de la coneja, ni 
metabólicos a nivel glucémico ni en la leptinemia. Sin embargo, el metabolismo lipídico se vió 
alterado en las fases tempranas-medias de gestación, cuando se está formando la placenta, 
pero las necesidades nutricionales del futuro feto todavía son bajas. Estas diferencias 
desaparecieron en el último tercio de gestación, cuando la madre presenta un metabolismo 
principalmente catabólico y el feto necesita un mayor aporte de nutrientes para poder llevar a 
cabo su crecimiento exponencial. Además, la RAG indujo cambios histopatológicos en la 
placenta, que reflejaron un incremento de las zonas de fibrosis de la decidua, una reducción de 
la vascularización y del número de trofoblastos en el laberinto, así como un incremento 
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significativo del porcentaje de apoptosis y de expresión de caspasa-3 en las tres partes de la 
placenta. Estos hallazgos fueron más acusados en el grupo de hembras restringidas durante 
toda la gestación. A consecuencia de ello, se pudo observar que el tamaño fetal en el día 28 de 
gestación se vio afectado en los dos grupos restringidos, aunque el peso del feto solo disminuyó 
significativamente en el grupo en que la RAG fue mantenida durante todo el periodo de 
gestación. Además, los fetos presentaron alteraciones en la proporción de sus órganos, con una 
significativa reducción del peso del hígado.  
En conclusión, el análisis conjunto de los resultados obtenidos en los diferentes experimentos 
indica que: 1) la RAG indujo cambios en la hemodinámica de la UCA y de la MCA. Todo ello 
generó cambios fenotípicos en el desarrollo fetal como reducción de peso, longitud o menores 
diámetros torácicos o biparietales, afectando también al desarrollo de ciertos órganos como el 
cerebro o el hígado, aunque el número de fetos desarrollados y neonatos no se modificó en 
ninguno de los casos, 2) estos resultados pueden ser parcialmente contrarrestados con la 
administración de SC aunque los posibles efectos vasodilatadores a nivel de la MCA deben ser 
estudiados y, por último, 3) las pautas de RAG estudiadas no produjeron cambios morfológicos 
en la madre, ni en sus concentraciones plasmáticas de leptina ni en su metabolismo glucídico. 
Sin embargo, alteraron su metabolismo lipídico en los periodos tempranos y medios de 
gestación, generando cambios en el fenotipo macroscópico y microscópico de la placenta de 
distinta manera e intensidad según el periodo en el cual la RAG fue aplicada. 
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Summary 
Fetal growth depends on an adequate maternal nutritional balance and a correct placental 
development. Imbalanced diets during gestation may predispose the mother and her offspring to 
suffering from pregnancy complications and abnormal fetal development, with long-term 
consequences for their health.  
Intrauterine Growth Restriction (IUGR), defined as the failure of a fetus to reach its genetic 
potential size, can be associated to multiple factors, such as placental insufficiency or maternal 
pathological diseases (e.g. undernutrition). In IUGR, the impairment in placental function reduces 
the oxygen and nutrient supply to the fetus, resulting in fetuses with low body weight at birth and 
possible disproportionate body growth. Such alteration may be associated with changes in the 
growth pattern of certain organs, such as the brain or the liver. However, the severity of the 
effects of undernutrition during gestation will depend on the time of exposure, the degree or 
intensity of the restriction and the type of food deprivation. 
Despite the multiple differences in placentation and fetal development among eutherian 
mammals, experimental animals such as rodents or sheep have been useful for the study of 
IUGR and placental insufficiency.  However, in the last years, there is a tendency to complete the 
results obtained from the aforementioned animal models with other eutherian mammals. In this 
sense, the employment of animals with a double functionality, biomedical modeling and livestock 
production, could reduce overlapping research and be a suitable alternative to the frequent 
employment of rodents. In this sense, the rabbit, which shares some physiological characteristics 
with the human (hemochorial placentation and accelerated fetal brain development) could be a 
suitable alternative.  
In the Mediterranean area, the rabbit is a well-established livestock animal (mainly for meat 
production). However, in recent years, the costs of feeding animals have undergone a significant 
increase, which can be more than 60% of the global costs of production. Thereby, many farmers 
are forced to establish food restriction protocols in their farms in order to reduce productive costs. 
This management may be beneficial when applied in the early stages of the pregnancy, as 
maternal metabolic necessities and fetal requirements for growth are low. However, the 
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consequences of such restriction in placental and offspring outcome in rabbits are not well 
established. 
Thereby, the objective of this thesis is to study, in the rabbit, the effects that a 50% maternal food 
restriction (MFR) application could generate in maternal, fetoplacental and neonatal statuses 
when this nutritional regimen is conducted in different gestational periods. Specifically, we have 
evaluated: 1) hemodynamic changes of the conceptus and morphometric parameters of the 
offspring in utero and at birth, 2) the effects of a vasodilator molecule based on the administration 
of Sildenafil Citrate (SC) and 3) the consequences that 50% MFR application has on maternal 
metabolism, placental structure and biometric measurements of the fetus.  
The objective of the first work conducted in this thesis was to investigate the impact of 50% MFR 
carried out from the post-implantational period (day 9 of pregnancy) to the end of gestation (day 
31 of pregnancy). In this work, we have evaluated conceptus hemodymanic changes (umbical 
cord arteries, UCA, and middle cerebral artery, MCA) by Doppler ultrasonography and fetal 
morphometry by echography at the end of the second third of gestation. At birth, we evaluated 
the effects of 50% MFR in the weight of the dams and the offspring outcome, in terms of biometry 
and mortality rate. The results of this trial reinforced the use of non-invasive techniques 
(ecography and Doppler ultrasonography) to detect early fetal growth disruption and changes in 
blood flow. Fetuses exposed to 50% MFR demonstrated lower end diastolic and higher systolic 
velocities at the UCA that generated changes in the mean time velocity and a tendency to higher 
pulsatility and resistance indexes respect well-nourished fetuses. Such alterations may be 
associated to a possible placental ischemia, also generated reductions in fetal biometry. 
Nevertheless, 50% MFR did not result in maternal body weight loss or higher neonatal death 
despite the reduced phenotype of the offspring. 
The second experiment of the thesis further investigated the findings of the previous study. In this 
sense, we employed the same level of MFR and the same period of exposure. Thus, we added 
an extra group that was treated with SC in the last third of gestation. The results of this trial, 
obtained on day 26-28 of pregnancy, reinforced the previous study, specifically, the reduced 
phenotype observed in the offspring and the alterations in placental level. Histologically, we 
observed that undernourished placentas changed at the decidua, showing a thinned section and 
increased amounts of poorly cellular fibrous connective tissue that extended multi-focally into the 
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labyrinth and surrounds, and replaced vascular channels with the collapse of the adjacent 
labyrinth structure. Fetal weight was significantly reduced. The treatment with SC improved 
placental development by increasing vascularity and vessel hypertrophy in the decidua and 
labyrinth. Nevertheless, although SC improved certain biometric parameters of the offspring, it 
could not improve the weight of the offspring. Thus, the administration of SC could have had 
resulted in blood flow alterations at the cerebral level and alterations in the hepatic function of the 
fetus that warrant further investigations. 
Finally, in the third experiment of this thesis, we decided to explore other time windows of the 
rabbit gestation. We sought to determine the consequences of the 50% MFR during the 
preimplantational period (from day 0 to day 7 of the pregnancy) or throughout gestation (day 0 
onwards). In both periods, 50% MFR did not result in maternal body weight loss or in alterations 
in leptin or carbohydrates metabolites. However, 50% MFR resulted in maternal lipid alterations in 
early to mid stages of the pregnancy, when placental formation begins but fetal necessities for 
growth are minimal. These alterations in lipid metabolities disappeared in late gestation, when 
maternal metabolism is catabolic and the fetus requires more nutrients to support its growth. The 
application of 50% MFR induced histopathological changes at the decidua (e.g. fibrosis) or 
reduced vascularization and number of trophoblast at the labyrinth zone. Furthermore, higher 
apoptotic levels and caspase-3 expression were found in undernourished placentas, in a more 
severe grade in placentas exposed to MFR during the whole gestation. Consequently, fetal 
growth, determined on day 28 of gestation, was affected in both restricted groups, although fetal 
weight was only reduced in the most challenged group. Furthermore, fetuses exposed to MFR 
evidenced alterations in the proportion of their organs, with a significant reduction of liver growth 
in both restricted groups. 
In conclusion, the data obtained from the different trials conducted over the period of this thesis 
suggest that: 1) MFR induced changes in the hemodynamic of the UCA and MCA. These 
changes altered the phenotype of the offspring, such as a reduced weight or shorter crown-rump 
length or lower thoracic and biparietal diameters. Thus, the development of certain organs, such 
as the brain or the liver was affected. However, the number of fetuses/neonates per female was 
not affected by MFR; 2) These results can be partially counteracted with the administration of SC 
in gestation, although the changes observed at the MCA require of further studies; lastly, 3) the 
protocols of MFR applied did not alter maternal body weight, leptin or glucidic metabolites. 
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However, these managements can affect lipid metabolites in early to mid stages of the pregnancy 
and alter the macro- and microscopic phenotype of the placenta in different manners according to 
the period of exposure to MFR. 
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Overview 
Placentation evolved as a reproductive strategy to ensure an adequate environment to the 
developing fetus. This transient organ a part from anchoring the fetus to the uterine wall and 
preventing immunological rejection of the fetus by the maternal immune system, enables nutrient 
and gases exchange. However, the success of this fascinating mammalian strategy relies on an 
adequate maternal nutritional status and metabolism. Thereby, imbalances in the allocation of 
resources due to poor maternal food intake or impairment in placental formation and/or function 
can lead to pregnancy complications and abnormal fetal development. 
 
Intrauterine growth restriction (IUGR) is defined as the failure of a fetus to reach its genetic 
potential size. This impairment in fetal growth can be associated to different etiologies, such as 
genetics, infections, malnutrition or placental insufficiency. These last two conditions are highly 
associated, in fact, the reduced maternal intake can impair placental function, which reduces 
utero-placental blood flow and consequently lowers oxygen and nutrient uptake by the fetus. As a 
result, the fetus may develop innate mechanisms of blood shunting to safeguard the growth of 
key organs, like the brain, even at the expense of the growth of other tissues (e.g. liver or skeletal 
muscle). 
 
Overall, the availability of a reliable animal model to study fetoplacental characteristics in IUGR 
pregnancies would be highly beneficial in order to develop diagnostic, preventive and therapeutic 
strategies in humans and animals. In the last years, the rabbit has emerged as a valuable model 
to investigate IUGR. The rabbit placenta develops as a discoid hemochorial placentation such as 
that of the human and rodents, and hemodynamic changes occurring during pregnancy are 
comparable with the human, with an important increase in maternal blood pressure throughout 
gestation. Thus, rabbit fetuses have an accelerated brain growth, being more similar to humans 
respect rodents. In addition, this model allows different approaches to induce placental 
insufficiency and IUGR (e.g. surgical procedures, pharmacological treatments or dietary 
protocols).  
Therefore, to provide a framework for the work conducted, the first two themes of this introduction 
will broadly review the different gestational phases and the important of an adequate maternal 
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nutrition and metabolism in gestation. The third theme will provide an overview of the effects that 
malnutrition can generate in conceptus development and growth (e.g. IUGR). The fourth part of 
the literature review will be focus on the current biomedical models employed to study IUGR. 
Finally, the fifth argument of the introduction will be dedicated to the rabbit as a model. In this 
section, the gestational phases, placentation and fetal growth of the rabbit will be detailed. 
Moreover, we will describe the methods for inducing placental insufficiency and IUGR in this 
model and finally we will introduce the rabbit as a livestock animal. 
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1. Pregnancy & placentation 
 
The pregnancy, also known as gravidity or gestation, is the carrying of an embryo or fetus inside 
the viviparous female. The time interval of a gestation is called the gestation period and, in 
mammals, begins when the zygote is formed and ends when the fetus leaves the uterus. The 
different processes that take place during the eutherian gestation such as preimplantation embryo 
development, implantation, placental formation and fetal development occur with great diversity 
among species. These differences are mainly based on the morphology and structure of the 
uterus, developmental stage of the embryo at the time of implantation and on endocrine and 
molecular interactions between the uterine and the embryonic tissues (Chavatte & Guillomot, 
2007). 
 
1.1.  Preimplantational phase 
 
In general terms, the preimplantation embryo development comprises the initial stages of 
mammalian development, before the embryo implants into the mother's uterus. This period 
begins after fecundation, when the zygote (Figure 1) multiplies its cells by several mitotic 
divisions. The result of these divisions is an increased number of embryonic cells or blastomeres. 
The embryo passes through different preimplantational embryonic stages, from 2 to 8 and 16 
cells, and then it is compacted reaching the morula stage (Figure 1). When blastomeres migrate 
to form a central cavity, known as blastocele, the embryo enters into blastocyst stage (Figure 1) 
(Mescher, 2013). The way these processes occur differ among species. From the moment that 
the blastocele becomes the yolk sac (YS) and the zona pellucida is lost, the embryonic 
development enters into a new phase in which the mammals of the different orders show great 
diversity in the mode of development, final form of the fetus and placenta, gestation time, etc. 
(Perry, 1981). Furthermore, the plasticity of the mammalian embryos during the initial period 
leads them to develop under varying environmental conditions, presumably throughout an 
adaptive metabolic reprogramming. However, this adaptation can induce immediate effects on 
the viability and development of the embryo, but it can also have pronounced and persistent 
effects into the adulthood, including effects on the reproductive performance of successive 
generations (Ashworth et al., 2009).  
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Figure 1. Sequence of events in early pregnancy (Adapted from LifeMap Sciences) 
 
1.2. Implantation phase 
  
The implantation phase begins when the blastocyst reaches the uterus and attaches to the 
uterine wall (Table 1). The development of the mammalian fetus is dependent upon a successful 
implantation of the blastocyst (Fleming et al., 2011). This essential step is regulated by the action 
of the trophoblast cells (TBs), which coordinate the complex processes of embryonic 
implantation, uterine spiral artery remodelling and initial development of the placenta (Watkins et 
al., 2015).  
 
Table 1. Timing of implantation events in mammals (Modified from Chavatte & Guillomot, 2007) 
Species 
Reaches uterus 
(day) 
Implantation 
(day) 
Gestational length 
(days) 
Mice 3 4.5 20 
Rabbit 3 6.5 31 
Human 3-4 6-7 280 
Pig 2 14 115 
Sheep 4 15 145 
Cow 4 19-20 280 
Horse 5-6 30 330 
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In general terms, at the time of implantation, the blastocyst shows two cell-type populations: cells 
allocated in the inner cell mass, named embryoblast, and cells differentiated in the outer cell 
mass, called trophoblast (TB). The TB will eventually give rise to the placenta, while the 
embryoblast will become the embryo (Figure 1; Sadler, 2011). The mode in which the TBs 
interact with the uterus for implantation varies among species. Two types of implantation are 
discerned according to this interaction, superficial and interstitial implantation. In superficial 
implantation, the TBs attach to the luminal epithelium, while in the interstitial implantation, the 
blastocyst lodges in groves or folds of the mucosa, invading the endometrium. Superficial 
implantation occurs in the rabbit, dog, cat and pig and interstitial implantation can be observed in 
human, mouse and guinea pig (Perry, 1981). 
 
TBs over the embryoblast pole proliferate and produce the chorion, necessary to bring the fetal 
and maternal blood systems into close contact (Rossant & Cross, 2001). During this process, TBs 
also differentiate in other cell subtypes or layers. The inner layer, which does not initially contact 
the maternal tissues, forms the cytotrophoblast (CT; Figure 1) and the outer layer facing the 
maternal tissue becomes the syncytiotrophoblasts (ST; Figure 1) by fusion of neighboring CT 
cells (Baergen, 2005). CT cells synthesize anti-inflammatory cytokines and embryonic factors to 
prevent adverse uterine reaction (Roth et al., 1996). In contrast, ST cells are a continuous 
specialized layer of epithelial cells, which can be in direct contact with maternal blood in species 
with interstitial implantation (Perry 1981; Wang, 2010). In these species, ST cells secrete 
hydrolytic enzymes, which are important for erosion, penetration and digestion of the surrounding 
tissue, providing nutrients to the embryo and allowing it to embed further into the endometrium 
(Ferrer-Vaquer & Hadjantonakis, 2013). 
 
The gastrulation begins with the differentiation of the embryoblast into two layers. The layer 
closest to the TB is the epiblast (Figure 1), which will give rise to the three germ cell layers 
(ectoderm, mesoderm and endoderm) that will form the embryo and contributes to the formation 
of different extraembryonic tissues such as the amnion or the umbilical cord. In contrast, the layer 
bordering the blastocele cavity is the hypoblast (Figure 1), which helps to the development of 
the extraembryonic mesoderm and YS and will be determinant in the establishment of the axial 
patterning of the body and nervous system (Ferrer-Vaquer & Hadjantonakis, 2013). Gastrulation 
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concludes with the appearance of the first somites. Somites are blocks of cells that originate 
many body structures, such as vertebrae, intervertebral disks or ribs (Resende et al., 2014). 
 
1.3.  Placentation 
 
Placentation is the development of the extra-embryonic membranes. This transient organ is 
involved in essential functions for pregnancy success, as it provides immunological protection 
against maternal immune system and pathogens (Gude et al., 2004). Moreover, the placenta is 
an endocrine organ, producing and secreting different hormones (e.g. estrogens, progesterone, 
leptin or placental lactogen) and growth factors (e.g. epidermal growth-factor or insulin-like 
growth-factors I and II), which can act by autocrine, paracrine and endocrine routes. Moreover, 
this vital and dynamic organ is highly specialized in exchanging gases and nutrients (e.g. 
carbohydrates, amino acids, lipids, vitamins or minerals; Gude et al., 2004). 
 
In general terms, regardless of the structure and interaction with the maternal tissues, in domestic 
animals, the placenta can be divided in three portions. The portion of the placenta that gives rise 
to the fetal membranes (chorionic villi, allantois, amnion and vestigial YS) and is in contact 
exclusively with the fetus is known as the fetal placenta. The portion of placenta that comes in 
contact with the maternal tissues is the decidua. Part of the decidua is in direct contact with the 
TBs, while another area creates a shell between the endometrium and the TBs, which grows over 
the embryo (Khan et al., 2012; Hayashi et al., 2014). The area between the chorionic villi and the 
decidua is known as the junctional zone, which is the site of growth factor and pregnancy-related 
hormone production (Georgiades et al., 2002).  
 
Decidualization is the process of differentiation of the spindle-shape stromal fibroblasts of the 
decidua into the plump secretory decidual cells, which create a pericellular extracellular matrix 
rich in fibronectin and laminin. The vascular structures formed in the decidua are critical for blood 
supply to the fetus. The main function of this vascular system is to control maternal blood blow 
and therefore regulate nutritional and gas exchange. In fact, these vascular structures possess 
nitric oxide synthases (NOS) receptors, which may facilitate blood supply to the fetus (Khan et al., 
2012; Hayashi et al., 2014). Furthermore, the decidua has to allow a very controlled invasion of 
the TBs. Soon after the placenta is established, it receives blood from both the maternal and the 
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fetal systems. The utero-placental blood circulation (from maternal to placental compartments) 
carries nutrient and oxygen-rich blood through the decidual spiral arteries and ultimately directly 
or indirectly, depending on the type of placentation, to the terminal villi, which contain fetal 
capillary vessels and STs. The developing fetus is connected to the placenta by the umbilical 
cord. The feto-placental blood circulation is composed by two circulations, in which the umbilical 
arteries carry deoxygenated and nutrient-depleted fetal blood and the umbilical vein carries fresh 
oxygenated and nutrient-rich blood circulating back to the fetal circulation (Wang, 2010). 
 
The relationship between the chorionic fetal membranes and the uterine wall at the histologic site 
of exchange is the basis for an important classification of the mammalian placenta (Figure 2; 
Furukawa et al., 2014): 
 
 Epitheliochorial: This type is considered the most superficial and lacks of significant invasion. 
No destruction or invasion of the maternal tissues occurs and no layers of endometrium are 
removed. It is observed in horses, pigs, ruminants, camels, dolphins, giraffes, and whales. 
 
 Endotheliochorial: The maternal uterine epithelium and connective tissue disappear and TBs 
come into direct contact with the maternal endometrial tissue. This type of placentation is 
found in dogs, cats, elephants, otters, ant bears and sea lions.  
 
 Hemochorial: Considered as the most invasive placentation, all maternal tissue layers 
disappear by erosion. Maternal blood comes into direct connection with the chorion. There 
are different subtypes depending on the number of TBs layers: 
 Hemomonochorial (primates) 
 Hemodichorial (rabbits) 
 Hemotrichorial (rats and mice) 
 
Another important classification of the placenta is based on the developmental structure of the 
chorionic villi: folded (pigs), lamellar (carnivores), trabecular (some primates), labyrinthine 
(rodents and lagomorphs), and villous (humans). The villi are where the fetal tissues come in 
direct or indirect contact with maternal blood and therefore the location for nutrient and gas 
exchange between mother and fetus (Burton et al., 2006). 
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Figure 2. Types of placentation according to the level of infiltration in maternal tissue. 
Figure legend: basement membrane (BM); cytotrophoblast (Cy); endometrium (En); fetal blood 
(FB); fetal vessel (FV); maternal blood (MB); maternal interstitium (MI); maternal vessel (MV); 
specific trophoblast (ST); syncytiotrophoblasts (Sy); trophectoderm (Te) (Adapted from Furukawa 
et al., 2014). 
 
1.4.  Fetal development 
 
The growth of the fetus can be modulated by different factors (e.g. metabolic and endocrine) that 
interact between maternal, placental and fetal compartments in a complex manner (Sparks & 
Cetin, 2006). Therefore, a physiological equilibrium of the mother (homeostasis) and a 
coordinated metabolic response in various tissues or organs to support the new physiological 
state (homeorhesis or teleorhesis) are required to achieve this cycle of life (Bauman & Currie, 
1980; Carlin & Alfirevic, 2008).   
 
This equilibrium is important in all gestational phases. Early pregnancy is the period in which the 
embryo remains almost microscopic and its energetic demands are low. However, in this initial 
period, the formation and development of the cell mass, which later will become the infant 
(embryogenesis), placenta and fetal membranes take place. Mid-pregnancy is the stage of 
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gestation in which the fetus continues to growth and the development of fetal organ systems 
(organogenesis) takes place. According to Sparks & Cetin (2006), two types of fetal growth can 
be observed: 1) qualitatively, in the development and maturation of internal organs, and 2) 
quantitatively, in increasing fetal size and weight. This last growth pattern is mainly observed 
during late pregnancy, when fetal body weight gain occurs and the fetus increases its energetic 
reserves (Gilbert & Jost, 1977). 
 
2. Maternal nutrition & metabolism 
 
Maternal diet must provide sufficient energy and nutrients to cover the high metabolic demands of 
the conceptus and the basal metabolism of the mother. Moreover, the mother needs to retain 
certain level of resources to cover the subsequent lactation and future pregnancies (Williamson, 
2006; Fowden & Moore, 2012). To cope with the high energetic necessities of the mother and the 
develop of her offspring, the additional energy requirements of pregnancy result from maternal fat 
accretion, tissue formation, expansion and oxygen consumption and the needs of the product of 
conception (fetus and placenta) (Goldberg, 2002; Williamson, 2006). However, determining 
maternal nutrient needs during pregnancy is complex because nutrient levels in tissues and fluids 
can be altered by hormone-induced changes in metabolism, shifts in plasma volume and changes 
in renal function (Picciano, 2003). Notwithstanding, what it is currently accepted is that pregnant 
diet is very similar to that for the non-pregnant (NP) state (Williamson, 2006). 
 
Maternal metabolism changes during pregnancy to ensure a continuous supply of nutrients to the 
fetus despite possible intermittent maternal food intake (Butte, 2000). Most of these changes are 
associated with alterations in maternal lipid profile (Herrera, 2002) and will depend on the level 
and type of nutrients that the mother and her developing offspring need for each gestational 
phase. Therefore, from a metabolic point of view, the gestation can be divided in two periods, 
early pregnancy (anabolic state) and mid-late pregnancy (catabolic state). 
 
Early pregnancy is primarily a time of preparation for the rapid demands for growth that will occur 
in late pregnancy. Therefore, this period, in which basal glucose and insulin concentrations do not 
significantly differ from NP values (Catalano et al., 1992), can be considered as an anabolic state 
in the mother (King, 2000). Moreover, there are remarked changes in maternal fat deposition 
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(Villar et al., 1992; Hadden & McLaughlin, 2009) in response to maternal hyperphagia (Douglas et 
al., 2007) and changes in the hormonal milieu (Ryan & Enns, 1988). Specifically, promotion of 
lipogenesis and suppression of lipolysis in this phase are mediated by changes in insulin, 
progesterone and cortisol (Hadden & McLaughlin, 2009), which increase hepatic production of 
triglycerides and enhance removal of these metabolites from circulation (Chandi et al., 2015). As 
a result, maternal leptin levels (hormone that helps to regulate energy balance) start to rise (Diaz 
et al., 2014). However, controversial results have been found regarding leptin metabolism in 
gestation, as this hormone is not only regulated by maternal intake and hormonal milieu, the fetus 
and the placenta are capable to synthesize this hormone during pregnancy (Hauguel-de Mouzon 
& Lepercq, 2001; Lepercq et al., 2001). 
  
In contrast, mid-late pregnancy is characterized by lipid mobilization in response to a decrease in 
insulin sensitivity, raising insulin resistance by 45-70% (Freemark, 2006; Lain & Catalano, 2007; 
Musial et al., 2016). Thereby, this gestational period can be considered as catabolic state. The 
resistance to insulin increases hepatic gluconeogenesis (formation of glucose and glycogen from 
non-glucose precursors via pyruvate) and lipolysis of adipose tissue. Thus, glucose uptake by 
maternal tissues is decreased, in line with the reduction of maternal energetic storage at the 
skeletal muscle (Diaz et al., 2014). Thereby, these metabolic changes increase serum 
maternal glucose and free fatty acid concentrations, allowing for greater substrate availability to 
the conceptus (Sivan & Boden, 2003; Lain & Catalano, 2007). 
 
2.1.  Metabolism of carbohydrates 
 
Glucose is the principal substrate for the placenta and for the fetus (Hay, 2006; Herrera & Ortega-
Senovilla, 2010), as fetal gluconeogenesis is minimal (Kalhan & Parimi, 2000). The placenta 
extracts around 40 to 60% of this metabolite by the uterine circulation, even though it only 
accounts for about 10% of the total uterine mass (Battaglia & Meschia, 1986; Bauer et al., 1998). 
Glucose reaches to the fetus after crossing the ST favored by a concentration gradient from 
mother to fetus. In fact, fetal glucose levels are 15-20% lower respect maternal concentration 
(Hadden & McLaughlin, 2009; Lager & Powell, 2012). Transport of glucose across the placenta is 
generally via protein-mediated facilitated diffusion and a number of glucose transporters (GLUTs) 
are involved (Gude et al., 2004). Moreover, glucose supply is determined by both blood glucose 
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concentration and uteroplacental blood flow (Baumann et al., 2002). Changes in blood glucose 
(e.g. imbalanced diets or gestational diabetes) or reduction in uteroplacental blood flow (e.g. 
impaired remodeling of the spiral arteries) can alter glucose transfer to the fetus leading to the 
observation of different fetal growth patterns (Baumann et al., 2002). Thereby, glycemic 
evaluation in gestation becomes essential. A valuable serum marker of glucose concentration is 
fructosamine, which reflects the degree of glycosylation of serum proteins, particularly albumin. 
This metabolite reflects the average blood glucose level over the previous 1-3 weeks (Bor et al., 
1999; Nansseu et al., 2015) and is used as an inexpensive method of screening for diabetic 
pregnancies (Roberts et al., 1983). 
 
2.2.  Metabolism of lipids 
 
Cholesterol is a key constituent of cell membranes and the precursor of hormones and metabolic 
regulators which are necessary for placental steroid synthesis (Butte, 2000; Woollett, 2001; 
Palinski, 2009). Thus, cholesterol is an important metabolic fuel for the developing fetus. 
Cholesterol reaches fetal circulatory system after crossing the STs (Palinski, 2009; Bartels et al., 
2012). Although fetus and placenta can both synthesize cholesterol (Herrera, 2002), most of the 
cholesterol is derived from maternal blood via an interaction of circulating cholesterol-carrying 
lipoproteins [low-density lipoproteins (LDL-c)]. The ST shows LDL receptors which allow the 
internalization of LDL-c by receptor-mediated endocytosis (Gude et al., 2004). In contrast, high-
density lipoproteins (HDL-c) are responsible for returning excess of cholesterol from peripheral 
tissues back to the maternal liver either in the pregnant or NP state (Kondo et al., 2003). 
Cholesterol is a fundamental substance during gastrulation as it moderates the sonic hedgehog 
proteins, which are involved in the early migration and survival of neural crest cells (Ingham & 
McMahon, 2001). Furthermore, it will contribute to the development of the brain and other fetal 
tissues (Baardman et al., 2013). 
 
Other important lipids for pregnancy success are triglycerides; in fact, these metabolites 
represent an important energetic deposit in maternal tissues (Herrera & Lasuncion, 1998). 
Triglycerides do not cross the placenta in a significant amount (Herrera & Lasuncion, 1998). In 
fact, maternal triglycerides are hydrolyzed and taken up by the placenta, where soon after they 
are re-esterificated to provide a reservoir of fatty acids for the fetus. Fatty acids are transported to 
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fetal liver, where they are re-esterificated, stored and released back into fetal circulation in the 
form of triglycerides (Herrera, 2002). 
 
3. Malnutrition & conceptus adaptations 
 
The term “maternal malnutrition” focus attention on mothers exposed to inadequate diets due to 
excesses (overnutrition) or deficits (undernutrition) in their food intake and/or imbalanced diet 
composition during the period of bearing and/or nurturing their offspring (Blossner & de Onis M, 
2005; Black et al., 2008). As a consequence, malnutrition can disrupt fetal growth trajectory which 
lead to the observation of disorders in fetal growth patterns, such as Intrauterine Growth 
Restriction (IUGR) giving way to Small for Gestational Age infants (SGA) or growth excess, which 
implies fetal macrosomia/overgrowth and is defined as Large for Gestational Age (LGA). 
 
Overnutrition and obesity are problems in developed and developing societies, leading to a burn 
in metabolic diseases such as Type II-diabetes (Gonzalez-Bulnes & Ovilo, 2012; Gonzalez-
Bulnes et al., 2015). However, maternal undernutrition is a severe public health issue in emerging 
countries but also in developed societies. In the developed world, undernutrition is usually 
associated to esthetical reasons (eating disorders and voluntary caloric restriction; Brett et al., 
2014). In emerging societies, undernutrition is related to limited access to high quality foods, 
wrong traditional habits, food taboos, low social statuses and limited knowledge about the effects 
of the condition (WHO, 2004). The FAO 2015 Hunger report (FAO, 2015) estimates that about 
795 million people are undernourished, mainly in sub-Saharan Africa and South-Central and 
South-Eastern Asia. Due to the reduced food intake, adult’s height is usually lower than 145 cm 
and body-mass index of less than 18.5 kg/m². These factors can predispose to adverse 
pregnancy outcomes, such as cesarean delivery, preterm birth, low birth weight (LBW), and 
higher rates of morbidity and mortality (Black et al., 2008; Shah & Shah, 2009; Han et al., 2012). 
 
3.1.  Placental adaptations 
 
There are increasing evidences in the literature suggesting that the placenta can act as a sensor 
of the maternal-fetal environment, adapting its morphology (Coan et al., 2010; Zhang et al., 
2015), function (Sibley et al., 2005) and cellular composition (Sandovici et al., 2012). These 
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adaptations contribute to optimize nutrient and gas exchange between the mother and the fetus, 
in line with the capacity of the mother to allocate her resources and the continuous signaling of 
the fetus for growth. However, adverse conditions in the intrauterine environment may determine 
placental morphology during gestation, which will depend on the type and duration of the 
exposure to the insult (Myatt, 2006). Morphological studies show that physiological remodeling of 
the maternal uterine vasculature into spiral arteries is deficient in IUGR pregnancies, due to 
inadequate TB invasion and proliferation (Pijnenborg et al., 2006; Toal et al., 2007). Failure of 
placental adaptations may result in placental insufficiency and lastly in fetal growth disruption 
(Sibley et al., 2010). IUGR is often a consequence of this ineffective function of the placenta and 
can be associated to a higher incidence of perinatal morbidity and mortality, as well as increased 
risk of suffering from cardiovascular and metabolic diseases in later life.  
 
Placental efficiency, usually evaluated in terms of fetal weight to placental weight ratio, has been 
used as a proxy of the intrauterine conditions and may indicate the different adaptations that the 
placenta can perform to favour or constrain allocation of resource according to maternal and fetal 
signals. In this regard, studies involving embryo transfer between breeds of different size has 
evidenced that placental size can be modulated according to the genetic potential for growth of 
the developing fetus and maternal size (Fowden et al., 2009). Although, placental weight usually 
positively correlates with birth weight, it has been demonstrated that lighter placentas could be 
more efficient respect those that are heavier, increasing nutrient delivery to support fetal growth 
under adverse conditions (Fowden et al., 2009). However, this measure not always tracks with 
placental nutrient transfer capacity estimated per placental surface area (Sferruzzi-Perri et al., 
2016). 
 
Placental adaptations in undernourished pregnancies have been reported in different species. In 
rodents, maternal food restriction by 15-50% reduces conceptus weight by 22-26% respect ad 
libitum pregnancies (Sferruzzi-Perri & Camm, 2016). However, although the exposure to caloric 
restrictions during the mouse gestation reduces conceptus weight, it has been noticed an 
upregulation of system A transport and different genes involved in nutrient exchange (Glut1, 
Slc38a1, Slc38a2, FABP4, FABP5) (Ganguly et al., 2012; Chen et al., 2013). These results may 
indicate that the placenta tries to compensate nutritional deficits by adapting its functional 
phenotype. Furthermore, in rats, 50% food restriction reduces by 25% conceptus weight and 
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increase apoptosis in the labyrinth and junctional zones. However, SNAT4 and GLUT1 
transporters are significantly increased (Belkacemi et al., 2011a, b). Other studies have shown 
different placental adaptations when oxygen concentration is reduced (hypoxia). In this regard, 
pregnant guinea pigs exposed to hypoxia showed unchanged or reduced fetal weight, but 
unaltered placental weight. These changes were associated with alterations in placental function, 
as evidenced by an increased diffusion capacity, but similar surface area and lower barrier 
thickness (Gilbert et al., 1979; Bacon et al., 1984). Thereby, maternal environment can shape 
conceptus phenotype and the placenta tries to adapt its functional and morphological phenotype 
to help meet the fetal drive for growth (Sferruzzi-Perri & Camm, 2016). 
 
Placental apoptosis has been found to be another factor regulating placental efficiency and fetal 
growth (Sharp et al., 2010). Apoptosis was first described by Kerr and colleagues in 1972 (Kerr et 
al., 1972) and refers to a type of cell death. This biological process by which the cell “programs its 
own death” has been extensively described by Hardy (1999) (summarized in Figure 3). Apoptosis 
involves a series of consecutive morphologically distinct phases regulated by the effector 
caspase pathway (Huppertz et al., 2006). This process occurs normally during development, 
aging and as a homeostatic mechanism to maintain cell populations in tissues (Jaattela, 2002; 
Elmore, 2007; Soni et al., 2010). In placental tissue, apoptosis is essential for invasion, CT fusion 
and ST function (Sharp et al., 2010). However, excessive placental apoptotic rates can be 
observed in cases of IUGR (Smith et al., 1997), preeclampsia (DiFederico et al., 1999; Genbacev 
et al., 1999; Allaire et al., 2000), hypoxia (Levy et al., 2000) and malnutrition (Belkacemi et al., 
2009; 2011a, b). In fact, the expression of p53 and the active form of caspase-3 is upregulated in 
the placental IUGR villi (Zhang et al., 2015). Thereby, these evidences suggest that these 
mechanisms of removing unnecessary cells by activation of the caspase pathway are essential 
for placental development, but exacerbate rates may induce placental dysfunction (Sharp et al., 
2010), resulting in a lower placental efficiency to exchange nutrients and gases between mother 
and fetus. 
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Figure 3. Schematic representation of the morphological and biochemical features of apoptosis in 
the cell (Modified from Hardy, 1999) 
 
3.2.  Fetal adaptations - IUGR 
 
The failure of the fetus to reach its genetically established growth rate is defined as IUGR (Froen 
et al., 2004; Albu et al., 2014). This impairment in fetal growth is associated with LBW, defined by 
the World Health Organization (WHO) as a birth weight less than 2,500 grams in the human 
newborn (WHO, 2004) or weights below the 10th, 5th or 3rd percentile given for a gestational age 
and sex (Bakketeig, 1998; Lackman et al., 2001). This condition affects around 5 to 10% of the 
human pregnancies and is the second primary cause of perinatal mortality, after prematurity 
(Nardozza et al., 2012). However, this pathological condition not only happens in humans, in fact, 
all eutherian mammals are susceptible to develop IUGR (livestock animals: Wu et al., 2006; dogs: 
Kliegman, 1989; Zone & Wanke, 2001; rabbits: Thakur et al., 2000; pigs: Campos et al., 2012; 
Ashworth et al., 2001; non-human primates: Davison et al., 2000; McDonald et al., 2013). 
 
It is important to note that not all small fetuses are IUGR (Alfirevic et al., 2010). In this sense, 
babies born fundamentally small but that have reached their intrauterine growth potential are 
known as SGA. This last term refers to a weight for gestation below a specific threshold, which 
suggests that a percentage of the smallness is due to constitutional or physiological causes and 
not because of pathological conditions (Figueras & Gardosi, 2011). Thus, IUGR term should be 
used only to the fetus (Kurjak et al., 2012), such distinction between IUGR and SGA is critical for 
antenatal as well as postnatal care (Ananth & Vintzileos, 2009). 
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3.2.1.  Etiology of IUGR 
 
The etiology of IUGR is multifactorial and scarcely understood, but it is thought to include a 
combination of maternal, environmental, fetal and placental factors negatively affecting fetal 
homeostasis (Table 2) (Sankaran & Kyle, 2009).  
 
Table 2. Causes of IUGR (Modified and completed from Sankaran & Kyle, 2009) 
Main causes of IUGR 
Maternal factors 
Undernutrition Naeye et al., 1973; Bergmann et al., 2008 
Maternal low birth weight Shah & Shah, 2009 
Anorexia Nervosa, maternal age, parity Rusell, 1982; Ong et al., 2002; Solmi et al., 2014 
Chronic Hypertension and Pre-eclampsia Lambert et al., 2014 
Systemic Lupus Erythematosus Feld et al., 2015 
Diabetes, renal disease Grivell et al., 2009; Gutaj et al., 2014 
Infections, HIV, Malaria Sullivan et al., 1999; Venkatesh et al., 2010 
Thrombophilic disorders, hypoxemia Alfirevic et al., 2002, Poudel et al., 2015 
Environmental factors 
Drug use- smoking, alcohol, illicit drugs 
Ong et al., 2002; Hofhuis et al., 2003;  
Bergmann et al., 2008; Carter et al., 2013 
High altitude, hypoxia, irradiation Haas et al., 1982; De Santis et al., 2007 
Placental factors 
Abnormal placentation, placenta insufficiency Bekmukhambetov et al., 2016; Kroener et al., 2016 
Chronic abruption, infarcts, focal lesions Ananth et al., 2005; Feist et al., 2015 
Chronic inflammatory conditions (villitis) Feist et al., 2015; Nowak et al., 2016 
Single umbilical artery, velamentous cord insertion, 
placental haemangioma 
Hasegawa et al., 2006 
Confined placental mosaicism Simoni & Sirchia, 1994; Wilkins-Haug et al., 1995 
Uteroplacental malperfusion Marcorelles, 2013 
Massive perivillous fibrin deposition Kostadinov et al., 2016 
Fetal factors 
Genetic conditions, malformations Weiner, 1989; Lumley et al., 2001 
Intrauterine infections Grivell et al., 2009 
Multiple pregnancy Houlton et al., 1981 
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3.2.2.  Blood flow redistribution in IUGR 
 
In the situation of chronic fetal hypoxemia or nutrient deprivation, the fetus redistributes its 
cardiac output to maximize oxygen and nutrient supply to the brain, heart and adrenal glands at 
the expenses of the growth of other tissues such as lungs, liver, skeletal muscle or skin (Peeters 
et al., 1979; Jensen et al., 1999; Cohen et al., 2015).  
 
This redistribution is triggered by the carotid body and endocrine and local factors in the fetus, 
which results in constriction of peripheral circulations and dilation of essential vascular beds 
(Giussani, 2011, 2016). To sustain the brain’s supply of oxygen, blood is shunted from the 
umbilical vein via the ductus venosus (DV) (Figure 4). The DV dilates and more well-oxygenated 
umbilical venous blood is shunted to the heart at the expense of hepatic flow (Fu & Olofsson, 
2007). This blood flow distribution can be 
evaluated in vivo by the insonation of different 
blood vessels. The middle cerebral artery 
(MCA) is the most frequently used due to its 
intracranial position. In this regard, cerebral 
hyperperfusion is characterized by a decrease 
in vascular resistance in the MCA (Fu & 
Olofsson, 2007) and by changes in the 
cerebroplacental ratio (CPR), an emerging 
predictor of adverse pregnancy outcome 
calculated by dividing the Doppler indices of 
the MCA by the umbilical cord arteries (UCA) 
(DeVore, 2015). Ex vivo detection of blood flow 
redistribution can be observed by changes in 
the brain or liver weight respect fetal weight 
ratio and brain weight respect liver weight ratio 
(BLR) (Anderson, 1972; Mitchell, 2001; Marton 
et al., 2013). 
    
 
    
 
Figure 4. Blood flow redistribution  
(Modified from Godfrey et al., 2012) 
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3.2.3.  Diagnosis of IUGR 
 
At the ultrasonographic scanning, signs of reduction in fetal biometry such as biparietal diameter 
(BPD) below the 10th percentile or abdominal circumference below the 5th – 10th percentile are 
presumptive of IUGR (Bozzetti et al., 2013; Suhag & Berghella, 2013). Moreover, abnormal blood 
flow in the uterine and fetal blood vessels is often associated to secondary changes in the 
placental vascular tree (Pomorski et al., 2012) and can be detected by changes in the blood 
velocity waveform.  
 
Figure 5. Indices used in obstetric Doppler and arterial flow velocity waveform. Doppler signs of 
placental dysfunction. A) increased Doppler index associated to placenta insufficiency. B) & C) 
progression of the sequence of deterioration. Figure legend: systolic peak velocity (SPV), end 
diastolic velocity (EDV) and time-averaged maximum velocity under the curve (TAMX) (Modified 
from Baschat, 2011). 
Regarding the obstetric examination, the uterine artery (UA) waveform reflects the blood flow 
resistance in the maternal vascular compartment of the placenta, principally the spiral and 
placental arcuate arteries (Baschat, 2011). However, despite UA blood flow assessment is 
commonly used as screening tool to predict adverse outcomes (Kampman et al., 2015), it has 
been demonstrated to be a poor predictor of IUGR and needs to be combined with additional 
tests (Cnossen et al., 2008). In this sense, the waveform of the UCA reflects the blood flow 
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resistance in the placenta and correlates with fetal condition and outcome of pregnancy (Marsal, 
2009). In a normal gestation, UCA resistance, determined by mathematical formulas [resistance 
indexes (IR) and pulsatility (IP); Figure 5] shows a continuous decrease. In contrast, in cases of 
placental insufficiency, when placental development is affected (≈30% of placental mass 
damage), end-diastolic velocities in UCA decrease and flow may become absent (Baschat, 2011; 
Bansal et al., 2016). When this abnormality extends to 60-70%, placenta blood flow becomes 
reverse (Figure 5; Baschat, 2011). These situations can generate nutrient and oxygen deficits, 
reduction in fetal growth and lastly fetal death. 
 
3.2.4.  Types of IUGR 
 
IUGR can be classified into symmetrical IUGR (type I, proportionate, intrinsic, hypoplastic) and 
asymmetrical IUGR (type II, disproportionate, extrinsic, hypotrophic). When fetal growth is 
impaired during the first or second period of pregnancy (early onset growth restriction; Krishna & 
Bhalerao, 2011), the fetus is more susceptible to develop symmetrical IUGR, characterized by a 
uniform reduction of the size. This type of IUGR is usually associated to genetic (Trisomies 13, 
18, and 21) and infectious factors (cytomegalovirus, toxoplasmosis or rubella virus; Mitchell, 
2001; Militello et al., 2009). In contrast, asymmetrical IUGR occurs mainly during the last period 
of the pregnancy (late onset growth restriction; Militello et al., 2009) and is characterized by a 
reduction in size of some organs, while other organs remain normal. Insufficient nutritional 
delivery to the fetus by maternal undernutrition (Bauer et al., 2003) or placental insufficiency 
(Levene et al., 1985) can predispose to the development of this growth pattern. 
 
3.2.5.  Therapies for IUGR 
 
Despite the multiple advances in obstetrics, there is currently non-effective treatment for IUGR 
available (Sankaran & Kyle, 2009). For many years, non-pharmacological treatments included 
bed rest, maternal oxygen administration, nutrient therapy or abdominal decompression; 
however, most of these approaches are not currently on use (Grivell et al., 2009). For all these 
reasons, clinical trials are currently underway to determine the appropriate therapy that could 
solve pregnancy complications diseases. In this sense, many of pharmacological candidates 
have been evaluated, such as Aspirin (Uzan et al., 1991; Leitich et al., 1997; Bujold et al., 2010) 
or anti-oxidant Tempol (Stanley et al., 2012a). 
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Nitric Oxide (NO) Therapies: Sildenafil Citrate 
NO is produced from arginine by calcium dependent NOS and its biological signaling is mediated 
by cyclic guanosine monophosphate (c-GMP) (Mergia & Stegbauer, 2016). NO produced by the 
endothelial and inducible NOS [Endothelial Nitric Oxide Synthases (eNOS) and Inducible Nitric 
Oxide Synthases (iNOS)] regulates embryo development, implantation and TB invasion (Krause 
et al., 2011). This potent stimulator of vasodilatation and angiogenesis is required during 
placental development (Purcell et al., 1999) and is necessary for adapting maternal circulatory 
system to accommodate the increased blood circulating volume during pregnancy without rising 
blood pressure (Serrano et al., 2004). In fact, different studies have observed that, during early 
IUGR conditions, NO concentrations at the fetoplacental compartment are increased as a 
compensatory mechanism to counteract the deficits in placental blood flow (Lyall et al., 1996; Xu 
et al., 2000; Pisaneschi et al., 2012). Thus, pharmacological inhibitors of NOS led to maternal 
hypertension and IUGR (Yallampalli & Garfield, 1993). 
 
Sildenafil citrate (SC, commonly known by its commercial name of Viagra®) has been widely 
used for counteracting erectile dysfunction problems (Ravipati et al., 2007). This selective 
phosphodiesterase type-5 (PDE-5) inhibitor prevents the hydrolysis of cGMP and increases NO 
bioavailability. Thereby, due to its vasodilator and angiogenic properties, this therapy could 
optimize placental function and alleviate IUGR in at-risk pregnancies (Pyriochou et al., 2007).  
 
The effects of SC have been tested in different animal models of IUGR. SC can improve certain 
phenotypic parameters of the fetus/newborn (Sánchez-Aparicio et al., 2008; Stanley et al., 2012b; 
Motta et al., 2015). However, SC efficacy for counteracting LBW is controversial. Studies in 
sheep with 50% maternal food restriction have shown that this drug increased fetal weight by 
14% (Satterfield et al., 2010). However, in other studies this effect had not been found (Ramesar 
et al., 2010; George et al., 2013; Motta et al., 2015) and may be associated to the animal model 
and the method for inducing IUGR employed.  
 
In woman, SC has been tested with promising results, improving maternal and fetal blood flow 
velocimetry and fetal well-being (Lacassie et al., 2004; Lin et al., 2012; Panda et al., 2014; Sun et 
al., 2014; Trapani et al., 2016). Currently, several clinical trials are underway to further test the 
usefulness and safety of SC treatments for IUGR (Ganzevoort et al., 2014). 
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3.3. The Developmental Origins of Health and Disease (DOHaD)  
 
Barker and colleagues firstly described an association between LBW and the higher risk of 
suffering from non-communicable diseases such as type II diabetes, hypertension or ischemic 
heart disease in adulthood (Barker & Osmond, 1986; Barker et al., 1989, 1993). These 
associations, referred to as “Fetal Programming” or DOHaD, suggest that the offspring exposed 
to a poor nutritional environment or environmental-induced perturbations develop intrauterine 
adaptations to counteract the deficits in nutrient and oxygen uptake. This re-programmation leads 
to permanent changes in the development and functionality of fetal organs that can predispose 
them to suffering from metabolic syndrome or other diseases in later life (Hales & Baker, 2001; 
Vaag et al., 2012). 
 
The clearest evidence of the relationship between maternal undernutrition, placental adaptations 
and fetal development occurred during the II World War. The Western regions of The Netherlands 
were struck by a period of severe food scarcity due to an embargo of food and fuel done by the 
Germans in response to the Dutch railway strike and their support to the Allied forces (Painter et 
al., 2005; Franzek et al., 2008). This period of hunger started in the winter of 1944 and finished 
with the liberation of The Netherlands in May 1945 (Roseboom et al., 2011). Although the famine 
lasted for 5 months, the restriction affected a previously well-nourished population, so caloric 
amount significantly decreased throughout the period of the embargo (Painter et al., 2005).  
 
The effects of the Dutch Famine on the developing conceptus changed according to the period of 
the pregnancy in which the mother was exposed to the famine. Roseboom et al. (2011) found that 
exposure to the famine in any stage of gestation reduced placental area (≈19 cm2 reduction). The 
exposure to famine during mid- or late pregnancy also reduced placental length and width, 
reinforcing the period of TB invasion and spiral artery recruitment as critical points. 
 
Despite placental adaptations, babies exposed to poor nutritional environment during early 
gestation were heavier than offspring unexposed to famine (Schulz, 2010; Roseboom et al., 
2011). However, undernourished offspring evidenced higher rates of obesity, altered lipid profiles, 
cardiovascular diseases and altered cognitive functions when they grew up (de Rooij et al., 2010; 
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Schulz, 2010). In contrast, those exposed to the famine only during late gestation were born small 
and continued to be small throughout their lives, and with lower rates of obesity. 
 
Following the Dutch famine example, the Chinese famine or the Biafran famine in Nigeria 
generated relevant data about the effects of undernutrition and DOHaD. Most of the studies about 
the effects of the Chinese famine found associations between undernutrition in utero and 
increased risk of mental disorders in adulthood (Susser & St Clair, 2013; Huang et al., 2013). In 
contrast, the Biafran famine studies demonstrated the association of fetal and infant 
undernutrition and the higher risk of suffering from hypertension and impaired glucose tolerance 
(Hult et al., 2010). 
 
4. Animal models for studying IUGR 
 
Because of all mentioned above, there is a serious necessity to understand the pathophysiology 
of IUGR and find an effective therapy to counteract IUGR. Seeing as experimental studies on 
humans are limited due to ethical constraints, translational research based on the use of animal 
models have become imperative.  
 
Recently, Swanson & David (2015) reviewed the advantages and disadvantages of the animal 
model employed for this purpose. Although the closest animals to humans in terms of 
implantation and conceptus development are the non-human primates (Ramsey & Harris, 1996; 
Blankenship & Enders, 2003; Fazleabas, 2007; Rutherford, 2012; Su & Fazleabas, 2015), the use 
of these animals for biomedical purposes presents several ethical constraints and these models 
are not always available. Thereby, most of the studies have been performed in rodents and 
sheep (Figure 6). However, in recent years, other animal models such as pigs or rabbits have 
emerged as suitable models for reproductive studies. 
 
Rodents are candidate models for placental studies due to their similarities in placental 
development (discoid shape and the exchange interface is hemochorial; Furukawa et al., 2014). 
In fact, this specie is the most used in research due to its easy management and handling, low 
costs and the wealthy information available in the literature.  
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Figure 6. Animal models employed for studying IUGR. Percentages represent the number of 
articles published over the last ten years in Pubmed database with the keywords “IUGR + animal 
of research” (From Jorge López Tello). 
 
Regarding the sheep, its main advantage is the occurrence of singleton pregnancies; however, 
placentation is not closely similar to humans. Other groups have used the sheep for elucidating 
the effects of high-altitude exposure during pregnancy (a main cause of IUGR by deficiencies in 
oxygen supply), either by natural conditions (Parraguez et al., 2006, 2011, 2013, 2015; Herrera et 
al., 2007, 2016) or by using hypoxic chambers (Allison et al., 2016). 
 
In pigs, Gonzalez-Bulnes et al. (2016a, 2016b) recently reviewed the use of this animal as a 
model for pregnancy complications. Due to the intensive selection for prolificacy and the limit of 
intrauterine space, the pig can be considered as a “natural model for IUGR”, as within the litter 
may coexist animals with an appropriate body weight and other with LBW. However, this variation 
within the litter is associated with increased preweaning mortality, variable weights at weaning 
and decreased growth performance (Campos et al., 2012). 
 
4.1.  Methods for inducing IUGR 
 
The methods for inducing IUGR can be classified as maternal, placental or fetal approaches, with 
more specific manipulations at each level (Schröder, 2003). Each method (Table 3) has its own 
pros and cons when addressing placenta insufficiency and IUGR pathogenesis. In this sense, 
some authors propose the ligature of uteroplacental vessels as the most precise method, since 
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Maternal intervention 
Maternal undernutrition 
Protein/caloric, micronutrient deficiency, selected nutrient deficiency 
Maternal hypoxaemia 
Altitude 
Hypobaric hypoxaemia 
Normobaric hypoxaemia 
- ↓ Maternal fractional inspired oxygen content, intratracheal nitrogen 
Carbon monoxide, anaemia, methhaemoglobinaemia, maternal hypertension 
Placental intervention 
Reduction/restriction of placental growth 
↓ Number of implantation sites (hemihysterectomy or carunclectomy) 
Maternal hyperthermia 
Separation of placentomes during pregnancy 
Interference with uteroplacental vasculature - fetoplacental circulation 
Partial occlusion of uterine artery 
Embolization of uteroplacental circulation 
Ligation of interplacental vessels or uterine artery 
Embolization via umbilical artery 
Fetal intervention 
Organ/gland ablation 
Hypophysectomie, hypothalamic–pituitary disconnection 
Thyroidectomy, radioactive iodine 
Pancreatectomy, nephrectomy 
Other 
Banding ascending aorta, fistula 
L-nitro-arginine methyl ester administration 
Gene manipulation 
 
this approach restricts both nutrient and oxygen supply. However, this procedure is usually 
performed on the last few days of pregnancy and is associated with high mortality rates (Eixarch 
et al., 2011). Genetic knock-out models are useful for determining the role of a genetic allele (e.g. 
eNOS: Kusinski et al., 2012 or Insulin Growth Factor II (Igf2): Coan et al., 2008; Dilworth et al., 
2010); however, the costs of producing these animals are usually high and these mutants are not 
always available in other animal species apart from rodents.  
 
Table 3. Methods for inducing IUGR and placenta insufficiency (Modified from Schroder, 2003)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As an alternative, diets either by excess or by deficits can induce changes in uteroplacental 
perfusion, resulting in placental alterations and IUGR (Beck et al., 2000; Sferruzzi-Perri & Camm, 
2016). Thus, these diets can be combined with other methods to understand placental 
adaptations under more stressful situations, such as hypoxia (Higgins et al., 2015) or knock-out 
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models (Sferruzzi-Perri et al., 2011). Underfeeding programs are based on low-protein diets 
(Snoeck et al., 1990; Bennis-Taleb et al., 1999; Gonzalez et al., 2016), macro- or micro-minerals 
deficits (Lisle et al., 2003; Liu et al., 2013), caloric restriction (McNeill et al., 2012; Chen et al., 
2013; Ganguly et al., 2014) or global nutrient restriction (Li et al., 2009; Akitake et al., 2015). The 
effects of these nutritional approaches on maternal physiology, placenta growth and function and 
offspring outcome (short- and long-term consequences) will depend on different factors:  
1) The period of the pregnancy in which the mother and the fetus are exposed 
2) The level of restriction applied 
3) The capacity of the mother to allocate her resources 
4) The capacity of the placenta to adapt and to transfer 
5) Fetal requirements for growth  
6) Litter size: monotocous vs polytocous species 
 
As previously mentioned in this literature review, the time of the pregnancy in which the 
conceptus is exposed to the restriction in nutrients is critical for its development. In this sense, 
maternal food restriction (MFR) in rodents is usually associated with placental and fetal weight 
reduction (Ahokas et al., 1983; Coan et al., 2010; Mayeur et al., 2013; Sferruzzi-Perri & Camm, 
2016). However, when mice are exposed to 50% MFR from day 1.5 to 11.5 of pregnancy (early 
stages of pregnancy; term on day ≈20), placental weight is reduced and other placental 
phenotype characteristics as well (no data available respect fetal weights) (Schulz et al., 2012). 
However, these differences are not maintained at the end of gestation and fetal weight is not 
reduced (Harper et al., 2015). These results, once more, reinforce what previously mentioned 
about the capacity of the placenta to recover its normal function despite the application of MFR 
and emphasize its incredible capacity to adapt its function and morphology to support fetal growth 
demands under stressful situations (Sferruzzi-Perri & Camm, 2016). 
 
In sheep, the effects of MFR on conceptus development are even more inconclusive and may be 
associated to the reduced litter size (usually considered as monotocus specie) and the length of 
gestation (pregnancy length ≈147 days). In this specie, the period of maximal placental weight 
gain occurs in the first half of gestation (from day 30 to 80 of pregnancy) (Heasman et al., 1999) 
and it has been demonstrated that placentas from mothers restricted between days 28 and 77 of 
gestation were heavier, but fetal weight was unchanged (Heasman et al., 1998). Moreover, MFR 
from early to mid-gestation can either enhance or reduce placental growth without affecting fetal 
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weight (McCrabb et al., 1992). Notwithstanding, when MFR is carried out during late pregnancy, 
lamb weight is reduced (Gao et al., 2008) and can affect the ontogeny of fetal organ growth and 
development (Gao et al., 2009). 
 
5. The rabbit as a model 
 
The European rabbit (Oryctolagus cuniculus) belongs to the Lagomorpha order (Yanni, 2004) and 
is the second mammalian specie most frequently used for scientific purposes in Europe according 
to the Seventh Report on the Statistics on the Number of Animals used for Experimental and 
other Scientific Purposes in the Member States of the European Union (European Commision, 
2013).  
 
This animal, phylogenetically closer to primates than rodents (Graur et al., 1996) and considered 
as a large animal model despite its halfway between small and large animal (Getz & Reardon, 
2012), is widely used for biomedical modelling in reproductive sciences because of its countless 
benefits. Rabbits are easy to handle and they have small life-cycle, with short periods of gestation 
(30-31 days) and lactation (30 days). The size of the animal allows serial blood sampling (Haneda 
et al., 2010; Mizoguchi et al., 2010) and imaging of conceptus development can be performed 
with standard ultrasound equipment (Chavatte-Palmer et al., 2008). Furthermore, hemodynamic 
changes in the rabbit placenta are comparable with the humans (Fischer et al., 2012; 
Lecarpentier et al., 2012), with high blood flow velocities in the UCA resembling human values in 
the second trimester (Polisca et al., 2010). 
 
Overall, rabbits are considered excellent models for toxicology (Carney et al., 2008; Hui et al., 
2014; Sweeting & Wells, 2015; Tarazona et al., 2016; Valentino et al., 2016), atherosclerosis 
(Fan et al., 2015; Tikoo et al., 2015; Baumgartner et al., 2016), orthopaedics (Knapik et al., 2013; 
Gui et al., 2015; Wei et al., 2015), surgery (Calasans-Maia et al., 2009), diabetes (Duff & Mc MG, 
1949; Duff & Payne, 1950; Duff et al., 1954; Haucke et al., 2014; Javadi et al., 2014; Zhou et al., 
2015) and reproductive studies (Foote & Carney, 2000; Fischer et al., 2012; Tarrade et al., 2013, 
2014; Arias-Alvarez et al., 2016). 
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5.1. Physiology & characteristics of the rabbit gestation 
 
Rabbits reach sexual maturity at 4-6 months of age (Macari & Machado, 1978; Foote & Carney, 
2000). In this animal, ovulation is induced by coitus and due to their high sexual receptivity of the 
dam, it can encompass the lactation and the subsequent gestation simultaneously (Lorenzo et al., 
2014). The gestation lasts 31 days. Rabbit’s utero is duplicated and independent, as they present 
two uterocervicovaginal canals (Weisbroth et al., 1974). This fact facilitates the study of the 
maternal and fetal genomic interactions by transferring embryos in reciprocal crosses between 
breeds of different genetic background (Moce et al., 2004). 
 
5.2. Preimplantation phase 
 
Preimplantational events in the rabbit (Figure 7 and Table 4) have been recently reviewed by 
Fischer et al. (2012). Fertilization occurs at ≈10 h post coitum (p.c.), the second polar body starts 
to be visible 14 h p.c. and the embryo genomic activation takes place in the 8- to 16-cell stage. 
After multiple cell divisions, the morula stage is achieved ≈60 h p.c. From day 4, the rabbit 
embryo starts to dissolve the zona pellucida and it is replaced by the neozona during day 5 p.c. to 
promote the implantation process in utero. On this day, the number of cells forming the blastocyst 
ranges between 1,291 to 9,536. These numbers increase on day 6 p.c. (80,000 to 100,000) 
according to Fischer et al. (2012) review. Another main characteristic of the rabbit embryo is its 
mucin coat (Seidel et al., 1976; Carney & Foote, 1990), which surrounds the embryo until the 
hatching of the blastocyst (Denker & Gerdes, 1979). This coat will disappear around day 6 of 
gestation (Kane, 1975). 
 
Figure 7. Embryonic development of the rabbit. A) Morula; B) Cavitating late morula; C) 
Blastocyst; D) Expanded blastocyst (Modified from Arias-Alvarez, 2010). 
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Table 4. Early pregnancy events in the rabbit (Modified from Weisbroth et al., 1974) 
 
 
 
 
 
 
 
 
5.3. Gastrulation & implantation phase 
 
As previously mentioned, gastrulation is the process by which the embryo establishes the three 
germ layers (ectoderm, mesoderm, and endoderm) and, in the rabbit, this process starts on day 6 
of pregnancy. Gastrulation is divided in 7 phases (Figure 8), in which implantation takes place on 
the stage 4, which corresponds to day 7-7.5 of pregnancy (DeSesso, 1997; Nishimura, 2001) and 
concludes with the appearance of the first somites. These structures appear around day 8.5 of 
pregnancy in rabbits (Beaudoin et al., 2003) and originate vertebrae, intervertebral disks or ribs 
(Resende et al., 2014). 
mplantation in the rabbit can be divided in two phases and will conclude with the beginning of the 
placentation at day 8 (Nishimura, 2001). The first phase, also called the “ob-placental 
implantation”, takes place on day 7 of pregnancy in the antimesometrial side of the uterus. This 
phase is characterized by the formation of TB knobs, cell fusion to produce ST before attachment 
to uterine epithelial cells (Hoffman et al., 1999) and form the YS placenta. The second phase 
occurs in the mesometrial side of the uterus around day 8 of pregnancy and is called “placental 
implantation”. In this phase, the TBs attach to the placental folds to form the chorioallantoic 
placenta. In addition, rabbit TBs attach to and invade the endometrium as ST, in a similar pattern 
to humans and primates. In contrast, the blastocyst attachment of rodents is via CT (Hoffman et 
al., 1999). 
Timetable of: early zygote and blastocyst development 
Hours Event 
0 Coitus 
22-26 2-Cell cleavage state 
30-34 4-Cell cleavage state 
38-42 8-Cell cleavage state 
46-52 16-Cell cleavage state 
41-75 Morula state 
60 Slight changes in peripheral cells destined to become TB 
70-80 Blastocyst reaches uterus (depend on length of oviduct) 
75 Appearance of blastodermic vesicle, Cleft appears to separate the primitive mass from TB cells 
90 
Enlargement of blastocyst and increased number of cells in TB 
Disc elongation and growth in posterior direction with slight thickening at anterior end 
Beginning of primitive streak formation with cell condensation on midline 
Primitive streak present in the posterior part of the disc 
Mesoderm begins to grow fanshaped from posterior end of disc 
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Figure 8. Gastrulation stages in the rabbit embryo (Modified from Fischer et al., 2012) 
 
5.4. Early placentation 
 
The early post-implantation embryonic nutrition in the rabbit embryo, prior to the definitive 
placentation, is based on maternal histiotrophic nutrition via YS placenta (Furukawa et al., 2014). 
This type of nutrition is based on maternally derived solutes and macromolecules. It is secreted 
from endometrial and uterine glands into the space between the maternal and fetal tissues via 
inverted YS (IYS) (Marshall et al., 2015). After crossing the YS, molecules enter into the 
exocoelomic cavity (primitive YS) and soon after molecules can be transferred to the embryo via 
the vitelline vessels. Other possible routes for nourishing the embryo is the periderm diffusion, as 
the keratinized dermal layer is not yet formed in the embryo (Carney et al., 2004).  
 
The IYS of the rabbit appears at day 9 of pregnancy from the lateral margins of the embryo 
(Figure 9) and the visceral YS (VYS) becomes increasingly vascularized between days 10 to 12 
of pregnancy. The VYS begins to expand wrapping itself around the embryo, concluding this 
process on day 13 of pregnancy. In contrast, the nonvascular portion of the YS begins to 
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degenerate by day 10 p.c. (Weisbroth et al., 1974). These events coincide with the onset of 
chorioallantoic placental circulation (Carney et al., 2004), which is formed from the TBs and 
allantois and is vascularized by the alllantoic vessels (Mess, 2014). 
 
Figure 9. Rabbit’s yolk sac. A) Schematic representation of the yolk sac between days 9 to 13 of 
pregnancy. B) Rabbit embryo and yolk sac on day 9 of pregnancy. C) Rabbit yolk sac on day 12 
of pregnancy. Figure legend: embryo (E), exocoelomic cavity (ECC), yolk sac (YS) and yolk sac 
cavity (YSC) (Modified from Carney et al., 2004). 
 
5.5. Definitive placentation 
 
Rabbits have a hemodichorial and bidiscoid type of placenta (Figure 10) (Furukawa et al., 2014). 
The establishment and development of the true chorioallantoic placenta occurs during days 10-17 
of pregnancy (Weisbroth et al., 1974). Histologically, rabbit placenta presents different 
compartments, the labyrinth zone (Lz), the junctional zone (Jz) and the decidua basalis (Db), as 
previously mentioned in this memory, but with particular characteristics. 
 
 Labyrinth zone: According to Furukawa et al. (2014), the maternal blood spaces and the fetal 
blood vessels in the labyrinth zone are separated by two layers of trophectoderm (T) in rabbit 
(Figure 10). The outer T, which comes into direct contact with the maternal blood, is 
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comprised of STs, which are joined to the underlying CT layer by adhesion junctions. The 
inner T is one layer of CT overlying fetal blood vessels. Therefore, rabbit placentation 
(hemodichorial; bilayer) is closer to humans (hemomonochorial; monolayer) than rodents 
(hemotrichorial; three layers) (Hayashi et al., 2014). 
 
 Junctional zone: The Jz in rabbit is composed of glycogen cells containing PAS-positive 
substances. These cells are transiently detected in mid-gestation and disappear before 
parturition (Furukawa et al., 2014). 
 
 Decidua basalis: The first decidual cells are observed from day 8 of pregnancy in rabbit 
(Larsen, 1963). The vascular structures of the decidua give off one or more efferent vessels, 
which rise through the trophoblastic portion of the placenta, branching profusely, especially at 
the fetal surface (Figure 11) (Carter et al., 1971). As it is demonstrated in humans (Schiessl 
et al., 2005) and rats (Purcell et al., 1997), rabbit placenta possess NOS receptors, which 
may facilitate blood supply to the fetus (Khan et al., 2012; Hayashi et al., 2014). 
 
 
Figure 10. Macroscopic and microscopic images of rabbit placenta at term, day 28 of pregnancy. 
(Figure belongs to the author, Jorge López Tello). 
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Figure 11. Ultrastructure of the rabbit placenta. (Figures A, B, C) Labyrinth structure of the rabbit 
placenta. Figure legend: Endoplasmic reticulum (*), fetal blood capillaries (F), fetal pericyte (P), 
nuclei (N1 and N2), maternal blood space (M), trophectoderm: T1 (syncytium) and T2 
(unicellular), gaps (open arrow) and small desmosomal (small arrow) junctions between layers 1 
and 2 (Figures A, B & C from Wooding & Burton, 2008). (Figure D) Maternal arterial system of the 
rabbit placenta on day 18 of pregnancy. Figure legend: Spiral artery (Sp) originated from uterine 
artery, connects to the arterial sinus (As) and some radial arteries (Ra). Secondary branches of 
radial artery (Ra2) send small branches into intervillous spaces (Is) (Adapted from Hayashi et al., 
2014). 
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5.6.  Fetal development 
 
Rabbit embryo-fetal development has been extensively described by Beaudoin et al. (2003). As 
previously exposed, the first somites appear on day 8.5 and from day 9.5 the cardiac mass as 
well as the rostral limb bud can be observed (Figure 12). The subsequent limbs will appear on 
days 10.5 and on day 12.5 they are disposed like wheel rays. Complete fetal appearance is 
achieved on day 19.5 of pregnancy. 
 
Rabbit’s organogenesis, like in other mammalian species, occurs roughly during the second third 
of gestation. After heart mass, which appears on day 9.5 of pregnancy, the liver and the first 
intestinal loops appear at 13.5 days. Intestinal growth in the cord concludes on day 17.5 of 
pregnancy. Abdominal vessels can be observed at 15.5 days and the cecal bud is present 
outside the abdomen at day 16.5 of pregnancy. On day 18.5, the bowel is returned back in the 
abdominal cavity and the umbilical ring is closed (Beaudoin et al., 2003). On the other hand, 
mesonephric ridge, which will give rise to the excretory system of the fetus appears on day 11.5 
(Beaudoin et al., 2003). Regarding the nervous system development, the first cerebral vesicle in 
the rabbit fetus can be observed on day 9.5 of pregnancy. The number of these vesicles increase 
throughout pregnancy, as on day 11.5 of pregnancy three cerebral vesicles can be identified and 
on day 12.5 this number increases up to five (Beaudoin et al., 2003). Notwithstanding, the growth 
and development of the rabbit nervous system (NS) is not limited to fetal life. In fact, in most of 
the animals, the NS development can be divided in three periods, “prenatal”, “perinatal” and 
“postnatal” (Harel et al., 1972). Rabbits are considered as “prenatal developers” and this 
characteristic is a principal advantage against rodents (“postnatal developers”) for investigating 
the effects of IUGR on NS, as motor and white matter development is similar to that of humans 
(Derrick et al., 2004). In rabbits, brain wet weight increases rapidly on the latest 10 days before 
birth, and continues growing after birth (Figure 12). On these last days of gestation, not only brain 
weight increases. Rabbit fetal growth is exponential, as it can be observed in the crown rump 
length (Figure 12). At day 20 of pregnancy, the fetus weighs less than 5 grams and thereafter, it 
gains about 2 g/day until day 22, followed by a weight gain of 4 g/day until day 24, and about 5 
g/day until day 30 (Weisbroth et al., 1974). This increment in fetal weight is in line with the 
exponential activity of the fetal liver to accumulate glycogen, as it significantly increases after day 
25 of gestation (Gilbert & Jost, 1977). 
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Figure 12. Rabbit fetal growth. (A) Rabbit embryo-fetal early development (Modified from Carney 
et al., 2007). (B) Rabbit brain and body weight velocity curves (Modified from Harel et al., 1972). 
(C) Rabbit crown-rump length throughout gestation (Modified from Weisbroth et al., 1974). 
 
 
5.7.  Methods for inducing IUGR and placental insufficiency in rabbits 
 
5.7.1.  Pharmacological treatment 
 
In 1996, Losonczy et al. (1996) evaluated the role of NO in the pregnancy-induced fall of vascular 
tone and arterial pressure. However, no data about the effects of this inhibitor on fetus or 
placental development was available from this study. Years later, the role of L-NAME in rabbit’s 
conceptus growth was determined. Lecarpentier et al. (2012) induced IUGR by the administration 
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of this inhibitor from day 24 of pregnancy. On day 28 of pregnancy, rabbit fetuses treated with L-
NAME were reduced in weight, in line with the hemodynamic alterations observed by Doppler. 
Furthermore, morphological examinations of the placenta revealed a substantial disorganization 
in the architecture of this organ when L-NAME was administrated. Following this line of research, 
Tarrade et al. (2014) found that the administration of L-NAME reduces volume density of fetal 
vessels, increases the volume and surface density of the maternal blood space, but does not 
affect TB volume density or surface density of fetal vessels. Overall, the administration of L-
NAME results in placental hypovascularization and IUGR in the offspring. However, the active 
metabolite of L-NAME (L-NOARG) was found in maternal and fetal plasma and thereby, limitating 
the use of this approach. 
 
5.7.2.  Electrical stress & ischemic approach 
 
Electrical and acoustic exposures during pregnancy are types of stress-induced approaches that 
can generate placental ischemic tissue and therefore result in hemodynamic alterations and 
impairment in the adequate feto-maternal exchange (Rosati et al., 1995; Haque et al., 2004). 
 
In 1974, Bal'magiya & Surovtseva (1974) found that the exposure to such stressors during the 
rabbit embryonic (4-16 days of pregnancy) or partly in the embryonic (16-22 days of pregnancy) 
periods of development, lead to death of the fetus. In contrast, when fetuses were exposed during 
the early periods of fetal development (22-23 days of pregnancy), fetal growth and development 
(organogenisis) were affected. However, when the exposure was carried out during the middle of 
the fetal period (24-25 days of pregnancy), electrical and acoustic stimulation did not change the 
weight of the fetuses compared with the control, although the normal weight ratios of the organs 
were altered. Lastly, stress applied at the end of the fetal period (25-27 days of pregnancy) led to 
an increase in weight of the conceptus (placenta and fetus) and acceleration of growth of fetal 
organs. 
 
Rosati et al. (1995) found that placental ischemia performed on day 21 of gestation resulted in 
placental growth restriction and IUGR. Furthermore, fetuses exposed to placental thermal injury 
had reduced brain and liver weights, with higher BLR, which suggests brain-sparing effect despite 
no difference in the weights of other organs, such as kidney or heart were found. Another method 
for inducing placental ischemia and lastly hypoxia is the use of an intraaortic balloon proximal to 
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the uterine arteries. This procedure, gold approach for studying cerebral palsy, which is a 
common finding in IUGR (Uvebrant & Hagberg, 1992; Blair & Nelson, 2015), results in cessation 
of blood supply to the uterus, fetal bradycardia (Tan et al., 1996) and fetal brain injury associated 
to free radicals (Tan et al., 1996, 1998) and brain edema (Tan et al., 1999). Furthermore, this 
method of hypoxia–ischemia can generate a broad of long-term consequences in the rabbit 
offspring, associated to brain white matter injury, such as hypertonia and postural deficits (Derrick 
et al., 2004; Tan et al., 2005; Derrick et al., 2007; Drobyshevsky et al., 2007). 
 
5.7.3.  Hypoxia & hyperoxia 
 
The effects of high altitude exposure (hypoxia; 12.75% O2) and hyperoxia (70-80% O2) in 
pregnant rabbits were determined by Darinskii & Surovtseva (1974). For these purposes, rabbits 
were placed in a pressure chamber (3 hours/day) from day 23 of pregnancy onwards. On day 30 
of pregnancy, the exposure to moderate hypoxia led to marked acceleration of body growth, 
primarily associated to changes in the growth and development of the skeletal musculature, 
meanwhile, the mass of the bones remained unchanged. These results contradict Chang et al. 
(1984) study, in which pregnant rabbits exposed to 13.2% oxygen concentration had pups with 
reduced values of birth weight, placental weight and liver ratio. In contrast, exposure to hyperoxia 
leds to marked delay in growth of the fetus, which was mainly associated to deficits in skeletal 
musculature, which suggest IUGR (Darinskii & Surovtseva, 1974).  
 
5.7.4.  Surgical method 
 
As previously mentioned in this literature review, the ligature of uteroplacental vessels is a valid 
approach to induce IUGR. This method could be considered as the most suitable for inducing 
IUGR, as this technique combines reduction in oxygen and nutrient supply, however, this 
approach is frequently associated to high mortality rates (Eixarch et al., 2011). As Table 5 
depicts, the percentage of vessel ligature vary from 20 to 50%, and is usually performed on the 
last third of pregnancy (days 21 or 25). Furthermore, the studies performed by using this method 
are usually designed to unravel the effects that such deprivation in blood supply could generate in 
fetal brain, heart and kidney development (Table 5). 
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Author 
Day of 
surgery 
% of 
ligature 
Effects 
Placenta Offpsring 
Harel et al.,   
1985 
26 30 NDA 
↑BR 
+ correlations: BoW, BR and HC 
Goldin et al., 
1987 
25 20-30 †Function †Brain function 
Bassan et al., 
2000 
25 20-30 NDA 
↓BoW ↓HC ↑HC/BW ratio 
↓Kidney weight ↓Renal glomeruli number 
Bassan et al., 
2010 
25 25 NDA 
↓BoW ↓HC ↑HC/BW ratio 
↓BW ↓Hemispheral protein level 
↓Astrocyte index ↔Total glial cell number 
Eixarch et al., 
2009 
21 
25 
20-30 
40-50 
↔Weight 
↑Mortality* (↔day25, 20-30%) 
↓BoW ↓CRL ↓BW ↑BR 
Eixarch et al., 
2011 
25 40-50 ↔Weight 
↑Mortality ↓BoW ↓CRL ↓BW ↑BR 
↑DV IP ↑Isovolumetric relaxation time 
↔MCA hemodynamics 
Eixarch et al., 
2012 
25 40-50 NDA 
↓BoW ↓BV ↑BV / BoW ↓Neurobehavioral test 
†Brain fractional anisotropy 
Figueroa et al., 
2012 
25 
20-30 
40-50 
NDA 
↓BoW ↓Renal glomeruli number  
↔Renal morphology †Gene expression 
Gonzalez-
Tendero et al., 
2013 
25 40–50 
↓Weight 
 
↓BoW ↓CRL ↓Abdominal girth ↓HW ↑ HW/BoW 
†Cardiomyocyte organization 
Illa et al.,  
2013 
25 40–50 NDA 
↑Mortality ↓BoW †Neurobehavioral test 
†Brain region infrastructures (↑in grey matter) 
van Vliet et al., 
2013 
25 40–50 NDA ↑Mortality ↓BoW ↓BW †Brain metabolite profile 
Batalle et al., 
2014 
25 40–50 NDA 
↓BoW (Until day 70 pp.)  
↔BV and fibers at day 70 pp. 
↓Brain network infrastructure 
†Neurobehavioral test 
↑Normalized GFA-weighted networks 
Torre et al.,  
2014 
25 40–50 NDA 
↓BoW ↓HW ↑HW/BoW †Fetal cardiac function 
↓Sarcomere length 
Simoes et al., 
2015 
25 40–50 
↓Weight 
 
↑Mortality ↓BoW ↓BW ↓BV  
†Brain metabolite profile 
Figueroa et al., 
2016 
25 40–50 
↓Weight 
 
↓BoW 
Deregulation of kidney vascular activity  
↑Oxidative stress damage in kidneys 
 
Table 5. Effects of uteroplacental vessels ligature on conceptus development in rabbits. Table 
legend: body weight (BoW); brain weight (BW); brain ratio (BR); brain volume (BV); crown-rump 
length (CRL); ductus venosus (DV); generalized fractional anisotropy (GFA); head circumference 
(HC); heart weight (HW); middle cerebral artery (MCA); pulsatility index (IP); postpartum (PP); †: 
altered; NDA: no data available. 
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5.7.5.  Nutritional managements 
 
Pregnant rabbits adapt their metabolism in response to their physiological stage (Boyd, 1936; 
Haugel et al., 1988; Wells et al., 1999; Haneda et al., 2010; Mizoguchi et al., 2010). During the 
first three weeks of gestation, pregnant rabbits have a positive energy balance and are capable of 
accumulating fat reserves (+65 g). In fact, pregnant rabbits can increase their food intake by 25-
50% (Fortun-Lamothe, 2006). Despite that, during the last pregnancy week, rabbit’s energetic 
balance turns negative, thereby, with possible consequences for fetal growth and the subsequent 
lactation (Fortun-Lamothe, 2006). Moreover, this adverse balance can reduce maternal 
reproductive performance and lifespan (Fortun-Lamothe, 2010). 
 
Accordingly, imbalanced diets or malnutrition, either by excesses or by deficits in nutrients intake 
during the rabbit gestation can generate a broad spectrum of short and long-term effects in the 
offspring. Furthermore, despite in most of the situations these dietary programs are only 
performed during the period of gestation. In determined situations, they can alter maternal 
homeostasis affecting the lactation and therefore having a rebound effect in the growth of the 
offspring (Hue-Beauvais et al., 2011, 2015). However, as it was previously mentioned in this 
literature review, the effects of such diets on maternal status, offspring development and growth 
will depend on the time of application of the diet, the level of fat inclusion or nutrient restriction 
applied and the response of the dam to such nutritional challenge.  
 
 High fat diets  
 
The effects that high fat diets can induce on pregnant rabbit outcome are good examples of the 
variation that these dietary treatments can have on the development and growth of the offspring. 
In this regard, Fortun-Lamothe & Lebas (1996) found that the inclusion of fat does not have any 
effect on mortality rate or in fetal weight. These results are supported by Xiccato et al. (1995), 
who fed pregnant rabbits with a fat inclusion level of 25 g/kg and did not result in variation of litter 
weight at birth. Moreover, other studies have found that rabbit gestation can be maintained with 
diets enriched with cholesterol, without affecting maternal prolificacy (Montoudis et al., 1999; 
Zilversmit et al., 1972; Tarrade et al., 2013; Leveille et al., 2014) or gestational length (Zilversmit 
et al., 1972). 
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However, when pregnant rabbits are fed with a high cholesterol supplementation (2%), pregnancy 
results in miscarriage on day 10 (Montoudis et al., 1999) and may be related to changes in the 
uterine fluids that could alter blastocyst development, resulting in failure of implantation or poor 
early placental formation. In this regard, Picone et al. (2011) found that cholesterol diets (0.2% of 
supplement) administered from the prepubertal period altered embryo gene expression in the 
early stages of the pregnancy (8–16 cell stage). Furthermore, this diet induced IUGR in the 
offspring and metabolic syndrome in adulthood. Few years later, Tarrade et al. (2013) found gene 
dysregulation at the blastocyst stage in key genes such as SLC2A1 or SLC2A3 (solute carrier 
family genes).  
 
These diets will not only have negative impacts in early embryo development, they are capable 
for altering maternal, placental and fetal homeostasis (Popjak, 1946; Zilversmit et al.,1972; 
Montoudis et al., 1999, 2003; Marseille-Tremblay et al., 2007; Hue-Beauvais et al., 2011; Picone 
et al., 2011; Frantz et al., 2012; Cordier et al., 2013; Tarrade et al., 2013; Leveille et al., 2014). In 
this sense, maternal plasma lipid metabolism is altered and hepatic function can be increased in 
response to an increment of cholesterol in the diet (Zilversmit et al.,1972; Montoudis et al. 1999, 
2003; Marseille-Tremblay et al., 2007; Tarrade et al., 2013; Leveille et al., 2014). Offspring weight 
can be reduced, resulting in IUGR (Popjak, 1946; Montoudis et al., 1999); despite in some cases 
no significant differences in the total lipid content of the offsprings can be observed (Montoudis et 
al., 1999). Furthermore, offspring metabolism (Montoudis et al., 1999) and liver function can be 
altered (Montoudis et al., 2003), predisposing the offspring to suffering from late-onset diseases 
such as atherogenesis (Palinski et al., 2001). 
 
These reductions in fetal weight may are associated to impaired placental phenotype and/or 
function. Popjak (1946) and Montoudis et al. (1999, 2003) found similar altered macroscopic 
appearance of the placenta and no changes in weight. In both studies, the color of the placenta 
was altered and may be associated to an excessive cholesterol accumulation within the cells of 
the fetal capillaries and decidual cells. Tarrade et al. (2013) found that this supplementation 
generated accumulation of lipids in the rabbit placenta at term, with a significant dysregulation of 
genes involved in transplacental transfers, which lastly affected fetal weight and induced IUGR. 
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 Maternal food restrictions (MFR) 
 
As it has been summarized in Table 6, the application of different food restriction protocols to 
pregnant rabbits can have important implications for the mother and her offspring outcome. The 
severity of such effects will depend on the period of gestation in which the restriction is applied, 
the physiological status of mother and her capacity to compensate the nutritional deficit when the 
challenge is over. Thus, the age of the mother and the number of parities can have important 
implications for fetal growth, as body composition, tissue deposition and energy retention can 
vary in nulliparous rabbit dams (De Blas & Wiseman, 2003). 
 
In the mother, undernutrition can alter body weight (Matsuzawa et al., 1981; Petrere et al., 1993; 
Cappon et al., 2005; Manal et al., 2010; Nafeaa et al., 2011; Symeon et al., 2015). However, in 
some occasions, this parameter can be unchanged or even increased as a consequence of the 
compensatory food intake when nutrients are back provided (Rommers et al., 2004; Menchetti et 
al., 2015a). In other situations, weight gain can be even higher in dams exposed to the restriction 
compared to well-nourished females (Petrere et al., 1993). However, it must be noticed that 
despite body weight is unchanged, some fat storages such as the perirenal fat can be affected 
(Menchetti et al., 2015a). Regarding other reproductive parameters such as fertility, gestational 
length, implantation or kindling rates, the application of these feeding regimens does not alter 
them (Matsuzawa et al., 1981; Rommers et al., 2004; Manal et al., 2010; Menchetti et al., 2015a). 
However, MFR can result in miscarriage, altered maternal preparturient behavior and metabolic 
alterations (Matsuzawa et al., 1981; Petrere et al., 1993; Manal et al., 2010; Menchetti et al., 
2015b). Finally, milk production can be reduced (Menchetti et al., 2015a) or unchanged (Manal et 
al., 2010). 
 
Changes in perinatal and postnatal growth as well as in mortality rates can be observed when 
MFR is applied in rabbits (Table 6). However, these effects depend on the level of restriction and 
the gestational window in which the restriction is conducted. As an example, a reduction of 1.32-
1.35 based on maternal requirements applied in early stages of the pregnancy does not affect 
litter size, although body weight of the offspring can be either unchanged or increased (Rommers 
et al., 2004; Manal et al., 2010). Thus, the aforementioned level of restriction reduces mortality 
rate at birth, may be associated to an excessive fatness of the well-nourished females rather than 
a direct effect of the MFR. In contrast, a significant reduction of food intake (administration of ≤60  
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Table 6. Effects of MFR on maternal homeostasis, placental development and perinatal and 
postnatal offspring growth. Table legend: altered (†); body weight (BW); delivery (D); 
maintenance requirement (MR); no data available (NDA); non-essential fatty acids (NEFA); 
perirenal fat weight (PFW); triiodothyronine (T3); weight (W). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Challenge Effects 
 Restriction Period Mother Placenta 
Perinatal 
offspring 
Postnatal 
offspring 
Matsuzawa 
et al., 1981 
Groups: 
150 g/day; 60 g/day; 
20  g/day 
6-20 
†BW 
↑Miscarriage 
(20g/day) 
↔ Implantational rate 
↓W 
(20g/day) 
↑Mortality (60-20g/day) 
↓BW (20 g/day) 
NDA 
Petrere  
et al., 1993 
Groups: 
150g/day; 75 g/day; 
15 g/day + ad libitum 
refeeding 
6-18 
†BW 
↑Miscarriage (15 
g/day) 
↔W 
↔Postimplantation loss, 
↔Mortality rate 
↓BW (male15g/day) 
↔BW (female15g/day) 
↑Malformations (15g/day) 
NDA 
Rommers  
et al., 2004  
1.35 of MR + ad 
libitum refeeding 
0-10 
↔BW; 
Compensatory feed 
intake 
↔Gestational length 
NDA 
↔Litter size 
↓Mortality rate ↔BW 
NDA 
Cappon  
et al., 2005 
Groups:  
150g/day (control); 
110 g/day;  
75 g/day;  
55 g/day;  
35 g/day;  
15 g/day + control diet 
refeeding 
7-19 ↓BW (≤ 55 g/day) NDA 
↓BW (≤ 75 g/day) 
No external or visceral 
malformations 
↑Unossified bones (≤ 75 
g/day) 
NDA 
Manal 
et al., 2010 
1.32 of MR + ad 
libitum refeeding 
0-10 
0-15 
0-20 
↑BW; Compensatory 
feed intake 
↔P4 concentrations 
↔Fertility, kindling 
rates 
†Preparturient 
maternal care (nest) 
↔Milk production 
↔Gestational length 
NDA 
↑BW at birth 
↓Mortality rate 
 
↑BW R15, R20 
(weaning) 
 
 
Nafeaa  
et al., 2011 
60% restriction 
(111g/day) 
0-15 
15-D 
†BW 
↓Serum total proteins  
NDA 
↔Litter size 
↓BW at birth (15-Delivery)  
↑Mortality rate (15-
Delivery) 
↓BW at 21st (15-
D) 
↑BW at 21st (0-
15) 
Menchetti  
et al., 2015a 
90g/day vs 130 g/day 
(control diet; 30.8% R) 
+ 130 g/day refeeding 
0-9 
9-18 
19-28 
 
↔BW kindling 
↔ Fertility 
↓PFW (9-18; 19-28 
groups) 
↓Milk production 
↔BW weaning 
NDA 
↔Gestational length 
↔Litter size 
↔BW at birth 
†Mortality rate: 
↔0-9; ↓9-18; ↑19-28 
↔Litter size 
weaning 
↔BW at 
weaning 
†Mortality rate: 
↔0-9; ↑9-18; 
↑19-28 
Menchetti  
et al., 2015b 
90g/day vs 130 g/day 
(control diet; 30.8% R) 
+ 130 g/day refeeding 
0-9 
9-18 
19-28 
 
†[leptin, insulin, T3, 
NEFA, glucose] 
NDA NDA NDA 
Symeon  
et al., 2015 
50% of MR 
7-19 
20-27 
↓BW (20-27) NDA 
↓Mortality rate 
† BW at birth (20-27) 
↔BW, feed 
intake 
↔ carcass 
↔ meat quality 
Goliomytis et 
al., 2016 
75% of MR 7-26 NDA NDA 
↓BW ↑Mortality 
↔Gestational length 
 
↓Litter weight 
(kindling) 
↑Mortality 
↔ Performance 
& meat quality 
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g/day) ranging from day 6 to 20 of pregnancy, a part from resulting in miscarriage, can affect 
body weight of the newborns and increase rates of malformations (Matsuzawa et al., 1981; 
Petrere et al., 1993; Cappon et al., 2005). The postnatal growth of these animals can be also 
affected in different manners according to the period of gestation exposed to the restriction. In 
this sense, exposure in early pregnancy can increase body weight (Manal et al., 2010; Nafeaa et 
al., 2011). In contrast, individuals exposed during late gestation can reduce their body weight at 
weaning (Nafeaa et al., 2011). Regarding the productive aspect of these animals, despite body 
weight of these animals at birth may be altered, studies evaluating the quality of their product 
have observed that meat quality is unchanged (Symeon et al., 2015; Goliomytis et al., 2016), 
suggesting a possible catch up during lactation. 
 
Finally, studies involving placental formation and function in rabbits exposed to MFR are scarce. 
It has been observed that MFR does not result in a compensatory increased weight of this organ, 
as it has been observed in other animal species (Heasman et al., 1998; Langley-Evans et al., 
1996). In fact, placental weight can be either reduced or unaltered (Matsuzawa et al., 1981; 
Petrere et al., 1993; Eixarch et al., 2011), reinforcing the inconclusive data exposed in previous 
sections. 
 
6. The rabbit as a livestock animal: importance of food 
restriction on fetal growth 
 
Apart from the biomedical use of the rabbit, this animal can be categorized as a farming animal, 
mainly for meat and fibre production (Allain & Renieri, 2010). In fact, the livestock production of 
the rabbit reaches to 1.8 million metric tons a year, which is mostly concentrated in Asia (48.8%), 
Europe (28.4%), America (18.1%) and Africa (4.7%) (Dalle Zotte, 2014). In livestock animals, the 
implications of DOHaD are outstanding for farm management (Chavatte-Palmer et al., 2015, 
2016; Gonzalez-Bulnes et al., 2016b), since animals affected by IUGR are penalizing profitability. 
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Rabbit livestock production is based on a cycled production in which this animal is normally under 
42-day semi-intensive rhythm [Artificial insemination performed on day 11 post partum (p.p.) and 
weaning is done at day 35 p.p. (Lorenzo et al., 2014)]. This rhythm can affect the critic energetic 
balance of the dam and may jeopardize the success of the subsequent gestations, as these 
females are always either pregnant, suckling or combining both processes within the same 
productive period (Figure 13) (Goliomytis et al., 2016). Consequently, the administration of an 
adequate nutrition will be essential for maintaining the health of the dam, but also for the 
economic viability of the farm and for the future success of the rabbit industry. 
 
Figure 13. Rabbit dam combining lactation and subsequent gestation. 
 
In commercial rabbit production, most of the productive costs are associated to animal feed, 
which can be more than 60% of the global costs of the farmer (De Blas & Wiseman, 2003). In 
addition, the low price of the rabbit at the first industrial sector and the drop of sales had meant 
that many farms were forced to close down, especially in the Mediterranean area. In the regular 
management of the rabbit farm is frequent to feed dams ad libitum or to appetite after mating. 
Thus, these types of feeding programs are also maintained during gestation and lactation 
(Nafeaa et al., 2011). However, these practices are expensive and in some cases, they are not 
fully recommendable since they can increase the fatness of the animal, especially when they are 
not pregnant and need to wait for the next insemination in the following cycle. This may result in 
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higher risk of health problems in the subsequent cycles, such as infertility or parturition problems 
(Fortun-Lamothe & Lebas, 1996).  
 
Although in previous sections of this introduction it has been listed the different effects that 
nutritional imbalances can generate on placental and fetal development, from a livestock 
perspective, the application of a moderate MFR strategy in specific and controlled periods of the 
gestation could be a practical nutritional approach, provided that fetal development is not 
prejudice. Thereby, this management could reduce productive costs, avoid maternal fattening and 
diminish mortalities at parturition. However, it is important to study the adequate threshold of MFR 
and the gestational windows in which this feeding program is applyied. 
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Objectives & thesis outline 
The main objective of the thesis was to determine whether moderate maternal food restriction 
protocols applied in specific time windows of the rabbit gestation could induce IUGR in the rabbit 
offspring. We also sought to determine whether Sildenafil Citrate could be a suitable therapy to 
counteract placental insufficiency and IUGR induced by maternal food restriction. In virtue of the 
double function of the rabbit, biomedical and productive, we addressed these objectives with 
these two perspectives in mind. 
 
These objectives were evalutated in three studies, which are: 
 
1. “Characterization of early changes in fetoplacental hemodynamics in a diet-induced 
rabbit model of intrauterine growth restriction” 
To determine the suitability of the rabbit as a maternal undernutrition IUGR model by fetal 
ecography and Doppler ultrasonography of conceptus hemodynamics and characterization of 
offspring growth at birth. 
 
2. “The effects of sildenafil citrate on feto-placental development and haemodynamics in 
a rabbit model of intrauterine growth restriction” 
To evaluate the effects of Sildenafil Citrate administration on fetoplacental hemodynamics, 
conceptus development and offspring growth at birth in the rabbit model of IUGR induced by 
maternal food restriction.  
 
3. “Competition for materno-fetal resource partitioning in a rabbit model of 
undernourished pregnancy” 
To determine the effects of different maternal food restriction protocols on maternal metabolism, 
histopathological study of the placenta and fetal development. 
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ABSTRACT 
The major goal of animal production is to obtain abundant and healthy meat for consumers. 
Maternal food restriction (MFR) is often applied in farms to reduce production costs. However, the 
suitability of MFR in livestock animals is questionable, as this management may compromise 
maternal fitness due to a severe negative energetic balance and can induce Intrauterine Growth 
Restriction (IUGR) and prenatal programming in the offspring. Here, we sought to determine, 
using pregnant rabbits, the consequences of MFR on maternal endocrine and metabolic status 
and conceptus development. Pregnant dams were distributed into three groups: CONTROL (ad 
libitum feeding throughout the entire pregnancy; mean pregnancy length being around 31 days), 
UNDERFED (50% MFR during the entire pregnancy) and EARLY-UNDERFED (50% MFR only 
during the preimplantation period, Days 0-7). Maternal leptin concentrations and glycemic and 
lipid profiles were determined throughout pregnancy, whilst conceptus development was 
assessed ex vivo at Day 28. Placental parameters were determined by macroscopic and 
histological evaluations and apoptotic assessments (TUNEL and Caspase-3). The main results of 
the study showed that, despite MFR altered maternal plasma lipid concentration (P<0.05), there 
were no effects on maternal bodyweight, plasma leptin concentration or glycemic profile. Fetal 
crown-rump lengths were reduced in both undernourished groups (P<0.001), but a significant 
reduction in fetal weight was only observed in the UNDERFED group (P<0.001). Growth in both 
undernourished groups was asymmetrical, with reduced liver weight (P<0.001) and significantly 
increased brain: fetal weight-ratio (P<0.001) and brain: liver weight-ratio (P<0.001) when 
compared to the CONTROL group. A significant reduction in placental weight was only observed 
in the UNDERFED group (P<0.001), despite both undernourished groups showing higher 
apoptotic rates at decidua and labyrinth zone (P<0.05) than the CONTROL group. Thus, these 
groups evidenced signs of placental degeneration, necrosis and stromal collapse. In summary, 
MFR may encourage the mother to make strategic decisions to safeguard her metabolic status 
and fitness at the expense of growth reduction in the litter, resulting in enhanced apoptotic and 
pathological processes at placental level and IUGR.  
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INTRODUCTION 
The major goal of animal production is to obtain abundant and healthy meat for consumers, which 
relies on adequate management of breeding animals and pregnancy periods [1]. In livestock 
animals, maternal nutrition has been largely recognized as a key factor for pregnancy success [1, 
2]. Periods of maternal food restriction (MFR) during gestation can result in offspring suffering 
from Intrauterine Growth Restriction (IUGR), defined as the failure of a fetus to reach its genetic 
potential size [3]. The same situation has been found in humans, with MFR having a strong 
impact of IUGR occurrence and a higher incidence of non-communicable diseases, like obesity, 
cognitive dysfunctions or cardiometabolic disorders [4-6]. 
In livestock animals, the intensive productive rhythms and the different farm managements aiming 
to reduce productive costs have led to a higher occurrence of IUGR in these animals [1, 7]. 
Thereby, affecting the quality of their meat (muscle fibers and marbling), athletic performance or 
fleece production [2, 8] and lastly resulting in poorer incomes for the livestock producer and lower 
quality products for the consumers. Despite these inconveniences, MFR protocols applied in 
specific periods of the pregnancy, such as the preimplantation period, in which the embryo’s 
requirements are low and the mother presents an anabolic status, could reduce productive costs 
and be an alternative strategy in farms [9, 10]. However, the pros and cons of such managements 
need to be further investigated, since inadequate nutrition from early gestation can influence 
placentation processes (specifically the allocation of trophectoderm and inner cell mass within the 
blastocyst [11]), which may impair placental development and function [12], compromising 
pregnancy outputs. In fact, experimental studies suggest that impaired placental structure or 
function (e.g. placental insufficiency) may contribute to IUGR in response to undernutrition [12, 
13]. Most of these studies have been performed in rodents [14], whilst the use of large animals is 
scarce. However, large animals (sheep, pig or rabbit) offer a wider range of benefits for the 
purpose of this assessment, as the results obtained from these trials, especially those based on 
MFR protocols, can be useful not only for biomedicine but also to unravel the aforementioned 
pros and cons of the application of MFR regimens to livestock animals.  
In the last years, the rabbit, considered as a livestock animal in the Mediterranean area (meat 
and fibre production [15, 16]), has emerged as a valuable model to investigate IUGR [17-31], as 
compared to a sheep or a pig, this animal does not need large animal facilities and gestational 
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length is shorter [term around Day (D) 31]. Thus, the rabbit develops a discoid hemochorial 
placentation and the fetuses have an accelerated perinatal brain growth, such characteristics are 
comparable with the human [32, 33]. Moreover, hemodynamic changes occurring during 
pregnancy are also similar to the human, with an important increase in maternal blood pressure 
throughout gestation [33, 34]. In rabbits, the effects of MFR during gestation [17, 30, 31, 35-41] 
vary depending on the period of the pregnancy exposed, the level of the restriction applied and 
the capacity of the mother to compensate, particularly during late pregnancy when fetal growth is 
maximal [42]. When it comes to the mother, MFR is usually linked to metabolic and hormonal 
changes [35-37] and low milk production [38]. Meanwhile, in the fetus, hemodynamic alterations 
and poor biometric outcomes can be observed [17, 30, 31, 39-41]. 
It has been previously shown using other animal species that MFR based on preconception or in 
ad libitum food intake can affect placental development [43], induce IUGR [44] and 
developmental programming of adult diseases in the offspring [45]. In previous work, using the 
rabbit as a model, we evaluated the effects of MFR based on ad libitum pre-pregnancy intake [30, 
31]. However, in these studies, MFR was applied when the rabbit embryo was already implanted 
(from D9 to term). MFR resulted in fetal IUGR (measured on day 28 of pregnancy and at birth) 
despite no differences in placental weight or in perinatal mortality were observed. Here, we 
sought to determine the consequences of MFR applied only during the critical period of 
preimplantation (D0-D7) or throughout the gestation (D0 onwards) on: 1) maternal food intake, 
endocrine and metabolic status of the dams, 2) conceptus development at term and 3) placental 
homeostasis determined by histopathological study and apoptosis quantification. 
MATERIALS AND METHODS 
Animals and experimental design 
Animals were housed in the facilities of the Polytechnic University of Madrid (UPM, Spain). All 
experiments were carried out in accordance with the National and Local rules of the Community 
of Madrid (Ref. PROEX 302/15), which meets the requirements of the Spanish policy for animal 
protection RD53/2013 and the European Union scientific procedures. Prior to the experimental 
phase (two weeks before mating), a total of 32 New Zealand x California rabbits (average 4.74 ± 
0.12 Kg) were fed ad libitum with a diet containing 16% crude protein, 37% crude fiber, 3.7% fat 
and 2400 kcal/kg of crude energy (NANTA, Madrid, Spain). During this period the food 
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consumption of each dam was recorded daily. Dams were inseminated (D0 of pregnancy) with 
fresh diluted semen (commercial extender, MA 24, Ovejero, León, Spain). Each dose contained 
at least 25 million spermatozoa in 0.5 ml of diluent (Magapor S.L., Zaragoza, Spain). Ovulation 
was induced with gonadoreline at the time of mating (20 µg/doe, i.m.; Inducel-GnRH, Ovejero, 
León, Spain). At this moment dams were randomly allocated into three groups: Ad libitum feeding 
along the pregnancy (CONTROL; n=9), 50% restriction of their previous ad libitum intake 
throughout pregnancy (UNDERFED; n=12) or restricted only during the preimplantation period 
(D0-D7; ≈22% of the total pregnancy) followed by ad libitum feeding until the end of pregnancy 
(EARLY-UNDERFED; n=11). Food intake was also recorded weekly in all experimental groups 
during gestation. 
Maternal blood sample collection 
Evaluation of metabolic parameters and hormones was performed in five dams per experimental 
group. Blood was obtained weekly (D0, D7, D14, D21, D28) by ear-puncture. Blood was placed in 
tubes with Ethylenediaminetetraacetic acid (EDTA) as anticoagulant and centrifuged for 15 min at 
1200 g to obtain ≈2 ml of plasma per dam. Concentrations of leptin were determined in a single 
analysis using the Multi-species Leptin RIA kit (Demeditec Diagnostics GmbH, Kiel, Germany). 
The assay sensitivity was 1.0 ng/ml and the intra-assay variation coefficient was 3.1%. 
Parameters relating to the glycemic (glucose and fructosamine) and lipid metabolisms (total 
cholesterol, high-density lipoproteins cholesterol [HDL-c], low-density lipoproteins cholesterol 
[LDL-c] and triglycerides) were measured on a clinical chemistry analyzer according to the 
manufacturer’s instructions (Saturno 300 plus. Crony Instruments s.r.i., Rome, Italy).  
Macroscopic study of the fetuses and placentas 
Dams were weighed and euthanized (30 mg/kg, IV marginal ear vein administration; Dolethal, 
Madrid, Spain) at D28. The gravid uterus was removed by a medial laparotomy and subsequently 
weighed. Fetuses were dissected from their extraembryonic membranes and classified according 
to the following criteria: viable (with a correct morphology and weight for the gestational age), 
mummified (dead in uterus with signs of shrivel and drying) or fetal resorption (residual placental 
tissue attached to the endometrium) (Fig 1). The implantation rate was estimated as the ratio 
between total numbers of implanted fetuses and corpora lutea present in the ovaries. In viable 
fetuses, crown-rump length and bodyweight were determined by the use of scales and calipers 
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prior to decapitation, after which brain and liver tissue were weighed. Brain and liver to fetal 
weight-ratios and brain to liver weight-ratio were obtained as indexes for IUGR [18, 46]. Finally, 
placentas from viable fetuses (except those selected for histopathological study) were weighed 
and decidua and labyrinth sections were separated and characterized by weight, length, breadth 
and thickness with scales and calipers. Placental efficiency was calculated as fetal to placental 
weight-ratio [47, 48]. 
 
Fig 1. Macroscopic images of rabbit conceptus at D28 of pregnancy. 
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Microscopic study of placenta 
The placentas closest to the left ovary were cut in half, fixed in 4% paraformaldehyde and 
switched to 70% ethanol the following day. Samples [CONTROL (n=8; one placenta was 
excluded for technical reasons), EARLY-UNDERFED (n=11), UNDERFED (n=12)] were 
embedded in paraffin and sectioned at 4 µm thickness with a semi-automated rotary microtome 
(Leica, Wetzlar, Germany). 
a) Histopathological study of placenta 
All samples were stained with hematoxylin and eosin and analyzed under a light microscope 
(Olympus BX40, Hamburg, Germany) by a trained pathologist blinded to the experimental groups. 
Stromal collapse of the labyrinth and decidual sclerosis of vascular channels were each graded 
and scored using the following criteria: unremarkable=0, mild=1, moderate=2 and severe=3. 
Other descriptive pathological features such as necrosis, mineralization and inflammatory 
infiltrates were recorded. The width of each placental layer (decidua, labyrinth and junctional 
zone) was analyzed by measuring five random fields of each layer under a 1.25x objective and 
obtaining the mean value. 
b) Placental apoptosis study 
Degree of apoptosis was determined using the ApopTag in situ apoptosis detection kit (Millipore 
Corp., San Francisco, USA) for terminal deoxynucleotidyl transferase dUTP-mediated nick-end 
labeling (TUNEL), according to the manufacturer's instructions and as previously described [49]. 
Sections were deparaffinized and treated with proteinase K (Roche Diagnostics GmbH, 
Mannheim, Germany). Endogenous peroxidase activity was blocked with 3% hydrogen peroxide 
in phosphate-buffered saline (PBS), and incubated with anti-digoxigenin conjugate in a humidified 
chamber at room temperature for 30 min. Sections were counterstained with methyl green. Ten 
random fields of each placental zone were photographed under a 20x objective and quantified 
using Image J software. The percentage of apoptotic cells was estimated as the number of 
TUNEL stained nuclei divided to the total number of total stained nuclei per zone × 100 [49]. 
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To corroborate the results obtained from TUNEL assessment, we also performed Caspase-3 
quantification. In brief, endogenous peroxidase activity was blocked by a 30 min treatment with 
3% hydrogen peroxidase in absolute methanol. Nonspecific binding was blocked by incubating 
the sections in 5% normal goat serum (sc-2043, Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) and incubated overnight with the primary antibody (1:25; caspase-3 antibody ab2171; 
Abcam, Cambridge, UK). After subsequent washes, sections were incubated with biotinylated 
anti-mouse secondary antibody (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 
subsequently with the avidin-biotin complex (ABC Vector Elite kit, Vector Laboratories, 
Burlingame, CA, USA). After chromogen incubation (Vector Nova RED substrate Kit for 
Peroxidase, Vector Laboratories, Burlingame, CA, USA), sections were counterstained with 
hematoxylin and analyzed under a light microscope (Leica DM IL, Wetzlar, Germany). The 
percentage of Caspase-3 positive immunostaining was determined as caspase-3 positive stain in 
a zone (pixels)/total surface of that zone (pixels) x 100. 
Statistical Analysis 
Statistical analysis was performed with SAS software (Statistical Analysis System Institute Inc., 
Cary, NC, USA). The effects of MFR in food intake, leptin and plasma metabolic parameters were 
evaluated by two-way analysis of variance (ANOVA). Maternal bodyweight and parameters 
related to conceptus development were analyzed by one-way ANOVA with maternal bodyweight 
at the beginning of the trial and number of fetuses per dam as covariates, respectively. If 
significant main effects were detected, T test (for parametric variables) or Kruskal-Wallis test 
(non-parametric variables) were used to compare averages among groups. Histological findings 
related to percentages were obtained by a Chi square test. All data were reported as mean±SEM 
and probabilities were considered significant at P<0.05. 
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RESULTS 
Early-MFR induced maternal food intake compensation in later gestation and 
circumscribed changes in lipid metabolism without affecting bodyweight, leptin 
concentrations or glycemic profile. 
Both undernourished groups had similar food intake during the 1st week of pregnancy and 
showed significant differences compared with the CONTROL group (Fig 2a). Once the restriction 
finished, EARLY-UNDERFED group significantly increased its food intake compared to the 
CONTROL group during the 2nd and 3rd weeks of pregnancy, but not during the last week of 
gestation, in which both groups significantly decreased their food intake (Fig 2a). These changes 
in dietary patterns were not associated to changes in the bodyweight of the dams at D28 
calculated after retrieval of the pregnant uterus (Fig 2b). Furthermore, MFR did not affect either 
plasma leptin concentrations (Fig 2c), glucose or fructosamine levels (Fig 2d-e), but did alter the 
circulating lipid metabolites in early to mid-gestation (D0 to D14). In this regard, during the 
preimplantation period (D0 to D7) higher concentrations of triglycerides were found in the 
CONTROL group compared to both undernourished groups (Fig 2f). Meanwhile, plasma 
cholesterol concentrations were only significantly higher in the UNDERFED group on D14 versus 
the CONTROL and EARLY-UNDERFED groups (Fig 2g). On D7, plasma HDL-c concentrations 
were significantly reduced in both undernourished groups (Fig 2h) despite the fact that within the 
same period of gestation, LDL-c concentrations increased in these two groups respect 
CONTROL values (Fig 2i). Lastly, LDL-c concentrations remained higher only in the UNDERFED 
group until D14 compared to EARLY-UNDERFED and CONTROL groups (Fig 2i). 
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Fig 2. Effects of MFR on maternal food intake, bodyweight and plasma leptin, glucidic and 
lipid concentrations during pregnancy. Number of pregnant dams per group employed for Fig. 
a) and b): CONTROL=9, EARLY-UNDERFED=11, UNDERFED=12; Number of pregnant dams 
per group employed for Fig. c) to i): CONTROL=5, EARLY-UNDERFED=5, UNDERFED=5. 
Statistical analyses were performed by ANOVA. Data presented as mean±SEM. Different 
superscripts indicate significant differences between groups (P<0.05).  
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Table 1. Effects of MFR on conceptus development. Number of pregnant dams per group: 
CONTROL=9, EARLY-UNDERFED=11, UNDERFED=12; Number of fetuses per group: 
CONTROL n=105, EARLY-UNDERFED n=126, UNDERFED n=117. Statistical analyses were 
performed by ANOVA. Data presented as mean±SEM. Different superscripts indicate significant 
differences between groups (P<0.01). NS non-significant differences. 
 CONTROL EARLY-UNDERFED UNDERFED P 
Litter size     
Gravid uterus (g) 762.96±52.82a 757.65±47.78a 572.19±45.74b <0.001 
Total number of fetuses (n) 12.11±1.20 11.90±1.09 10.33±1.04 NS 
Viable fetuses (n) 11.66±1.16 11.18±1.08 9.75±1.00 NS 
Mummified fetuses (n) 0.22±0.19 0.36±0.17 0.16±0.16 NS 
Fetal resorptions (n) 0.22±0.20 0.36±0.18 0.41±0.17 NS 
Implantation rate (%) 88.69±9.06 92.27±8.01 93.37±7.63 NS 
Fetuses     
Crown-Rump length (cm) 9.90±0.09a 9.45±0.08b 9.13±0.08c <0.001 
Fetal weight (g) 42.10±0.67a 41.10±0.60a 35.67±0.63b <0.001 
Head weight (g) 10.08±0.12a 9.78±0.10a 8.87±0.11b <0.001 
Trunk weight (g) 31.48±0.54a 30.89±0.48a 26.25±0.51b <0.001 
Brain weight (g) 1.03±0.01a 1.06±0.01a 0.96±0.01b <0.001 
Brain ratio (%) 2.49±0.04a 2.63±0.04b 2.77±0.04c <0.001 
Liver weight (g) 3.59±0.09a 3.21±0.08b 2.68±0.09c <0.001 
Liver ratio (%) 8.42±0.15a 7.60±0.14b 7.41±0.14b <0.001 
Brain:Liver ratio 0.31±0.01a 0.37±0.01b 0.39±0.01b <0.001 
Placenta     
Placental Efficiency 7.0±0.12a 6.76±0.11a 7.51±0.12b <0.001 
Total placenta weight (g) 5.99±0.15a 5.91±0.14a 4.67±0.15b <0.001 
Decidua     
Weight (g) 1.56±0.05a 1.52±0.04a 1.22±0.04b <0.001 
Length (cm) 3.55±0.07a 3.72±0.07a 3.24±0.07b <0.001 
Breadth (cm) 1.43±0.04 1.38±0.03 1.37±0.04 NS 
Thickness (cm) 0.40±0.02a 0.37±0.01a 0.31±0.01b <0.001 
Labyrinth zone     
Weight (g) 4.12±0.12a 3.88±0.11a 3.13±0.12b <0.001 
Length (cm) 3.66±0.05a 3.57±0.05a 3.28±0.05b <0.001 
Breadth (cm) 2.68±0.06a 2.60±0.06a 2.35±0.06b <0.001 
Thickness (cm) 0.52±0.02a 0.49±0.02ab 0.46±0.02b <0.01 
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MFR disrupted fetal growth trajectory but did not alter the number of viable fetuses at D28. 
MFR reduced the weight of the gravid uterus in the UNDERFED group compared to the 
CONTROL and EARLY-UNDERFED groups, despite no differences in the number of fetuses per 
litter or in implantation rate (Table 1). Fetuses in the UNDERFED group showed the lowest 
crown-rump length and fetal weight (total, head and trunk) while the EARLY-UNDERFED group 
only showed a significant reduction of crown-rump length when compared to the CONTROL 
group. Brain and liver weight were significantly lower in the UNDERFED group when compared to 
the CONTROL and the EARLY-UNDERFED groups (Table 1). In the EARLY-UNDERFED group, 
liver weight was significantly lower than in the CONTROL group. However, no difference was 
found in the absolute weight of the brain between these two groups. The assessment of brain 
ratio showed a significant increase in both undernourished groups, while liver ratios were equally 
reduced in EARLY-UNDERFED and UNDERFED compared to the CONTROL. Thus, brain: liver 
weight ratio was higher in both restricted groups with respect to the CONTROL group.  
MFR altered placental development and resulted in histopathological changes and higher 
apoptotic levels. 
Placental development was altered in both undernourished groups with a more severe effect 
when MFR was carried out throughout gestation. MFR reduced placental weight only in the 
UNDERFED group although a compensatory placental efficiency was observed (measured as 
fetus-to-placenta weight-ratio; Table 1). Decidua and labyrinth sizes were reduced in this group 
except for the decidua breadth, which did not show significant differences among groups. In the 
EARLY-UNDERFED group, labyrinth thickness showed intermediate values between the 
CONTROL and UNDERFED groups. No other differences were observed between groups within 
the remaining macroscopic parameters measured. 
Significant histological changes are summarized in Fig 3. The most notable changes in the 
placenta occurred in the UNDERFED group, which showed the lowest decidual width value (2.04 
± 0.32 mm) compared to the CONTROL (3.19 ± 0.32 mm) and the EARLY-UNDERFED groups 
(3.08 ± 0.29 mm) (P<0.05). Thus, the decidua of the UNDERFED group had fewer vessels, most 
of which contained hyalinized and sclerotic walls and lesser supporting stroma than the other 
groups (Fig 3). The labyrinth stroma in both restricted groups was significantly reduced in width 
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compared to the CONTROL group (2.46 ± 0.14, 2.04 ± 0.19 and 3.03 ± 0.20 mm, for EARLY-
UNDERFED, UNDERFED and CONTROL groups, respectively; P<0.05). The reduced width 
corresponded with the stromal collapse of the labyrinth which contained lesser cellularity 
(vascular endothelium and trophoblasts) than the CONTROL group. Thus the UNDERFED group 
showed moderate to severe signs of collapse followed by the slightly less severe EARLY-
UNDERFED group (Fig 3). Necrosis was observed in all experimental groups without significant 
differences (Fig 3). Mild mineralization was associated with the necrosis and was likewise 
insignificant between groups (Fig 3). The width of the junctional zone was similar between groups 
(CONTROL: 0.42 ± 0.08 mm; EARLY-UNDERFED: 0.35 ± 0.07 mm and UNDERFED: 0.30 ± 
0.09 mm; P>0.05). Mild heterophilic inflammation was observed in the three layers of all the 
experimental groups and was within normal limits for this organ (Fig 3).  
Concerning placental apoptotic rate, higher rates determined by TUNEL assay were found in both 
undernourished groups at the decidua and labyrinth zones (Fig 4a). At the junctional zone, only 
the UNDERFED group evidenced a significant higher rate when compared to the EARLY-
UNDERFED and CONTROL groups (Fig 4a). Results from the assessment of caspase-3 levels 
(Fig 4b) were similar to those found in TUNEL assay in decidua and junctional zone. In contrast, 
the labyrinth showed higher rates of immunostaining in the UNDERFED group followed by the 
EARLY-UNDERFED group and compared to the CONTROL group. 
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Fig 3. Histological findings of the rabbit placenta at D28 of pregnancy in CONTROL, 
EARLY-UNDERFED and UNDERFED groups. Figures A to C: Labyrinth (Lz) and junctional (Jz) 
zones of the rabbit placenta in the three experimental groups. (D & E) CONTROL AND EARLY-
UNDERFED groups. Densely cellular labyrinth with endothelium lined vascular channels and 
trophoblasts. (F) Labyrinth of the UNDERFED group with variably spaced endothelium lined 
vascular channels separated by collagen fibers (stromal collapse) and trophoblasts. Figures G to 
I: Junctional zone in the three experimental groups. (G) CONTROL group. Dense connective 
tissue matrix supporting stromal cells, trophoblasts and blood capillaries that extend into the 
labyrinth. (H) EARLY-UNDERFED group. Dense connective tissue containing stromal cells and 
trophoblasts. (I) UNDERFED group. Dense connective tissue slightly thinner and supporting 
fewer stromal cells and trophoblasts than the two other experimental groups. The overlaying 
labyrinth contains moderately spaced vascular channels with decreased cellularity. Figures J to L: 
Decidua (D) in the three experimental groups. (J) CONTROL GROUP. Normal decidua with large 
vascular sinuses, stroma, fibrin and necrosis. (K) EARLY-UNDERFED group. Large vessel within 
the decidua surrounded by abundant edematous stroma. (L) UNDERFED group. Markedly 
thinned decidua layer with spaced vessels containing hyalinised walls, a thrombus, and 
surrounded by dense stromal collagen. Number of placentas per group: CONTROL=8, EARLY-
UNDERFED=11, UNDERFED=12; Statistical analyses were performed by Chi square test. In the 
charts and table different superscripts indicate significant differences between groups 
(P<0.0001), NS non-significant differences.  
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Fig 4. Apoptosis assessments of the rabbit placenta at D28 of pregnancy. (a) Apoptosis 
quantified by TUNEL (positive staining) in decidua, junctional zone and labyrinth. (b) 
Localization and percentage of Caspase-3 (positive immunostaining) in decidua, junctional 
zone and labyrinth. Number of placentas per group: CONTROL=8, EARLY-UNDERFED=11, 
UNDERFED=12; Statistical analyses were performed by ANOVA. Data presented as 
mean±SEM. Different superscripts in the charts indicate significant differences between groups 
(P<0.05).  
DISCUSSION 
The current study shows that MFR applied to pregnant rabbits, despite the absence of significant 
changes in maternal bodyweight, plasma leptin concentration or glucidic metabolites, affects 
maternal lipid concentrations during early to mid-gestation but not during late gestation, when 
fetal growth is exponential. MFR applied only during the preimplantational period did not result in 
low fetal weight, but was enough to disrupt crown-rump length and impair organogenesis. 
Consistent with these findings, severe alterations on placental and fetal development can be 
observed when MFR is maintained throughout gestation (Fig 5). 
Fig 5. Summary illustration showing the effects of MFR in the EARLY-UNDERFED and 
UNDERFED groups on placental and fetal outcome. 
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The lack of effects of MFR on maternal bodyweight found in the current study supports previous 
studies in rabbits [30, 38, 41] and differs from other animal species in which the application of 
MFR resulted in maternal bodyweight loss [rodents: 50-53; sheep: 54, 55; primates: 56, 57]. 
These differences between species and experimental studies may be related to feeding 
management (ad libitum feeding vs maintenance requirements), fat stores prior to the 
experimental phase, or may be as well associated to reproductive strategies adopted by the 
mothers [58]. In this sense, undernourished dams had similar implantation rates and litter sizes 
compared to the CONTROL group. These results may suggest that undernourished mothers do 
not invest more than indispensable in their offspring growth, as a preventive strategy for future 
gestations and for their own energetic balance [58]. Despite the fact that offspring growth was 
affected, undernourished females could have accumulated resources to deal with the lactation, to 
guarantee a better offspring feeding, postnatal survival and growth and therefore ensure the 
transmission of maternal genes to future generations [58]. 
Concomitantly, plasma leptin concentrations did not decline in any of the groups in our study, 
opposite to previous works in rabbit [37], mouse [51, 59] and sheep [55]. We hypothesize that the 
absence of differences in our study may be explained by different facts. At first glance, the most 
obvious reason could be related to the number of animals sampled. However, sample size was 
calculated according to the study of Menchetti et al. [37], which found variations in leptin profile 
using a similar number of pregnant rabbits. Other explanations may involve an increased 
production of leptin either by maternal, placental or fetal tissues [52, 60]. This hypothesis may 
reinforce the idea that despite the restriction, food amount could be enough to satisfy maternal 
and fetal requirements. Expression of leptin-RNA in maternal adipose and fetoplacental tissues 
should corroborate this idea. Lastly, leptin concentrations could be influenced by hormonal milieu, 
specially insulin and/or glucose [61], estrogens [62] or glucocorticoids, which have been shown to 
induce leptin expression [63]. 
In contrast, maternal plasma lipids changed but only in early to mid-gestation. Such period of 
pregnancy can be considered as an anabolic state, due to the low requirements of the developing 
offspring [64, 65]. In contrast, we did not observe any variations in lipid profile during the last third 
of gestation, a period of accelerated breakdown of fat depots to satisfy fetal demands [66, 67]. In 
this regard, plasma cholesterol and LDL-c concentrations increased in the undernourished groups 
during the period comprising D7 to D14 of pregnancy, suggesting a certain level of fat 
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mobilization may be needed to deal with the implantation process [68], yolk sac formation and the 
establishment of the chorio-allantoic placental circulation [69]. In contrast, HDL-c concentrations 
raised in the CONTROL group to return excess of cholesterol from peripheral tissues back to the 
liver in response to an adequate level of resources [70]. Furthermore, maternal triglycerides 
concentrations were lower in both undernourished groups which may be a mechanism to 
increase deposition of fat in maternal adipose tissue for lactation [71]. Overall, these findings may 
reinforce, once more, the aforementioned strategies adopted by the mothers to constrain 
allocation of resources during late gestation on behalf of themselves and future lactation. 
Following this argument, the placenta is central to this “tug of war” over nutrient allocation as it is 
the surface area for exchange between mother and fetus [58; 72]. Experiments based on genetic 
and dietary manipulations have demonstrated that the placenta interprets fetal and maternal 
interests, adapting its phenotype and function according to resource availability [72-74]. An 
example of these fascinating adaptations is that undernourished placentas can overcome MFR 
and maintain or even increase their nutrient transfer capacity to help maintain fetal growth [50]. In 
our study, placental weight was reduced in the UNDERFED group. Such finding supports the 
hypothesis that the preimplantational period may be a critical timing for placental establishment, 
since the same level of MFR applied after implantation (D9 of gestation in rabbits) did not reduce 
placental weight [31].  
Conversely, no gross macroscopic differences were found in the EARLY-UNDERFED, reinforcing 
previous findings in sheep that were only restricted during early-mid gestation, and then returned 
to normal feeding [75]. Interestingly, the microscopic assessment of placental thickness showed a 
significant reduction in labyrinth expansion in both undernourished groups, which supports 
previous work [35]. The progressive reduction in the surface area of the labyrinth may affect 
placental nutrient transporters and contribute to the poor fetal outcome. In rats, MFR by 50% 
downregulated GLUT3 transporter expression, resulting in offspring with IUGR [76]. Furthermore, 
in a primate model of MFR [77], expression of glucose and amino acid transporters (GLUT1, 
TAUT, SNAT2, LAT1, and LAT2) were reduced as well as placental and fetal weights. Future 
work should evaluate such findings in our rabbit model of MFR and its connection with IUGR.  
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The reduction in the size of the decidua only observed in the UNDERFED group could be 
associated to two different processes. Firstly, a reduced trophoblast invasion could have impaired 
the correct remodeling process of the spiral arteries. Thus, the high incidence of sclerotic 
processes in the decidual vascular bed only observed in the UNDERFED group could be linked to 
the high circulating levels of cholesterol observed in this group on D14. In this sense, lipid 
peroxides and oxygen radicals can alter endothelial cells, resulting in fibrin deposition in the 
vessel walls [67]. Consequently, the arterial sinuses system in the rabbit, which can be identified 
within this period of gestation [78] and is responsible to retain maternal blood flow and then 
supply it to fetal area could be altered, resulting in IUGR. On the other hand, the reduction in 
decidua size could be a mechanism of these placentas to support fetal demands for growth by 
depletion of their glycogen reserves allocated in the small uninucleated cells of this placental 
section [79], and therefore may explain the increase in placental efficiency and the reduction in 
weight. However, this last effect remains speculative in this study; further investigations should 
corroborate this hypothesis and determine placental glycogen storage in restricted placentas of 
rabbit dams, as glycogen reserves in the murine placenta are an important source of glucose in 
the final stages of gestation [80]. However, what we have demonstrated is that imbalanced diets 
during pregnancy generate higher rates of apoptosis that could have affected placental 
development and function. Our study sets the bases on placental apoptosis in rabbit placenta at 
term and is in line with the range of degree of apoptosis reported in previous studies of MFR [49] 
and placental localization in mouse [81], showing higher rates of apoptosis in the decidua with 
respect to the other zones. Thus, this study has corroborated that apoptosis in placenta tissue is 
a biological phenomenon and could be a mechanism of placental remodeling [82], that may be 
associated to physiological degenerative mechanisms of the rabbit placenta near term [79, 83]. 
However, MFR significantly increases their rates, which may have resulted in placental 
insufficiency and therefore in IUGR. 
As expected, UNDERFED fetuses evidenced the clearest signs of IUGR, with reductions in fetal 
size (weight and length) and organs (brain and liver). This reduction in fetal weight induced by 
MFR has been previously demonstrated in other animals such as rodents [53, 84] and sheep [85]. 
Our data have revealed that MFR applied only during the preimplantational period did not reduce 
fetal weight despite that both fetal size and organogenesis were affected. The results obtained by 
the ratios assessments, suggest certain level of asymmetric IUGR in both MFR groups; 
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reinforcing the innate mechanisms of vasodilation and blood shunting of the fetus to safeguard 
the growth of key organs like the brain (process known as “brain-sparing effect”), even at the 
expense of the growth of other tissues (e.g. the liver, thymus or skeletal muscle) [31, 86, 87]. The 
possible postnatal consequences of these prenatal adaptations induced by MFR remain unclear 
in our model. In previous work, rabbit offspring developed in a MFR environment evidenced 
altered eating, drinking and locomotor behaviors [88], which may suggest changes in brain 
network organization. In humans, IUGR infants with brain sparing, showed worse 
neurodevelopmental and behavioural outcomes than those without signs of such mechanism [87]. 
In rodents, as recently reviewed by Sferruzzi-Perri and Camm [12], MFR can induce early 
modifications in cerebral structure, contributing to late-onset diseases in the offspring. Moreover, 
the cost of sparing the brain reduced liver mass in both undernourished groups, which is highly 
important for neonatal life, as it enables fat deposition and acts as a source of growth factors and 
glycogen. In addition, this prenatal reduction of liver mass along with the possible hepatic gene 
dysregulation already reported in IUGR rats [89] could predispose the offspring to suffering from 
metabolic diseases in adulthood, such as obesity, insulin resistance and type-2 diabetes [90-92]. 
These adaptations are likely to have implications for subsequent postnatal growth and the quality 
of the meat as recently reviewed by Chavatte-Palmer [2, 8]. In sheep, 50% MFR resulted in 
offspring with increased fat deposition and altered glucose metabolism [93]. However, the most 
recent studies performed in rabbits, have not found differences in meat quality parameters 
restricting dams by 50% [94] or 75% [95]. 
In conclusion, the present study has helped increase awareness of the effects of MFR in 
gestation. The results of the present study suggest that MFR may induce strategic decisions in 
the mothers to safeguard their bodyweight and metabolic status at the expense of reductions in 
the growth of their litters. These maternal decisions are associated with moderate changes in lipid 
metabolism in circumscribed periods of the pregnancy (mainly during embryo development and 
early placental formation), but not in leptin secretion or glucidic metabolites. Thus, MFR impairs 
placenta development and enhances apoptotic processes, which ultimately could reduce its 
functionality and lastly induce IUGR. Fetuses will be reduced in size, and organogenesis can be 
impaired, even if the exposure only occurs during the preimplantation period. Therefore, these 
results should be taken into consideration when these kind of nutritional strategies were applied 
in livestock animals, as no clear evidence are found in the mothers, but the progeny can be 
affected. Furthermore, this study reinforces the use of rabbits as valid biomedical models in the 
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perinatal field. Additional studies are needed to determine the possible consequences induced by 
the MFR in the offspring fitness. 
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In human medicine, maternal undernutrition is a world-wide health issue, since nutritional 
imbalances during the pregnant stage may have significant consequences in the adequate 
development of the offspring. Among them, consequences range from miscarriage, IUGR, fetal 
programming and perinatal death (Triunfo & Lanzone, 2015) to life-threatening complications for 
expectant mothers (Vasiljevic et al., 1996). 
The same applies to other eutherian mammals. Thereby, many animal species have been used 
to unravel the pathogenesis of placental insufficiency and IUGR. Among them, rodents are the 
most recognized biomedical models and therefore the most frequently used for these studies 
(Schroder, 2003). However, nowadays, part of the society is concerned about the number and 
adequacy of animals used for scientific purposes. Hence, the employment of animals with a 
double functionality, biomedical modeling and livestock production, could reduce overlapping 
research and be a suitable alternative to the frequent employment of rodents. The rabbit is a well-
established livestock animal in the Mediterranean area and, as previously exposed, this 
mammalian specie is the second most frequently used for scientific purposes in Europe 
(European Commision, 2013). However, the use of rabbits for pregnancy complications studies is 
scarce, despite hemodynamic changes and feto-placental features in this animal are much closer 
to humans (Derrick et al., 2004; Polisca, et al., 2010; Fischer et al., 2012; Lecarpentier et al., 
2012) than what is in rodents. 
Following this argument, the three works conducted within the period of this thesis were designed 
and performed with the double function that the rabbit possesses. In these studies, we employed 
the same level of MFR, 50% of the daily ad libitum non-pregnant state. The reason for employing 
a restriction based on preconception or ad libitum food intake, instead of maternal nutrient 
requirements for gestation, was that previous studies performed in other animal species had 
already reported that restriction based on ad libitum intake impairs placental development (Schulz 
et al., 2012) and generates IUGR (Dywer et al., 1995). Furthermore, by employing this approach, 
we ensured that the dietary treatment was customized to cover the necessities of each animal, 
avoiding possible over- or under-feeding that could alter our results. Moreover, the novelty of this 
thesis was that the restriction was applied in specific time windows of the rabbit gestation: during 
the preimplantation period (day 0-7 p.c.); from implantation to delivery (day 9-31 p.c.), and 
throughout gestation (day 0-31 p.c.). Combining these strategies, we have established a valuable 
rabbit model of IUGR by MFR.  
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Then, as we knew that currently there is non-effective treatment for IUGR available, we evaluated 
SC effectiveness for th e first time in a rabbit model of IUGR, as previously studied in the sheep 
model of undernutrition (Satterfield et al., 2010) and in other animal models, such as knock outs 
(Stanley et al., 2012b, 2015; Dilworth et al., 2013), pharmacological treatments (Cauli et al., 2010; 
Ramesar et al., 2010; Herraiz et al., 2012; Nassar et al., 2012; Motta et al., 2015) or other 
approaches (Miller et al., 2009; George et al., 2013; Luna et al., 2015, 2016). Thereby, in this 
work, we were able to determine the consequences of MFR on pregnancy outcome, but at the 
same time, we characterized the effects of SC, which is currently being tested in pregnant women 
(Ganzevoort et al., 2014). 
In this thesis, we have employed different techniques to characterize placental function (e.g. 
Doppler ultrasonography or immunohistochemistry). Our results encompass the macroscopic and 
the microscopic features of IUGR. Thereby, this thesis provides an important view of the different 
processes and consequences that nutritional imbalances can generate in pregnant rabbits and in 
the develop of the offspring, with both points of view, the biomedical modeling and the livestock 
production. Moreover, taking into account the results obtained from these trials, we can establish 
what type of MFR strategy is the most suitable to induce IUGR, but we can also suggest whether 
the application of these feeding managements could be positive or not before the establishment 
in the industry. 
In the first chapter, the global aim was to evaluate the suitability of the rabbit as a model and MFR 
as a valid approach to induce IUGR. The early diagnosis of IUGR was performed by echography 
and Doppler ultrasonography on day 21 of pregnancy (≈70% of the total pregnancy), being 
corroborated by in vivo measurements of the newborns. To achieve our goals, we restricted 
pregnant animals from day 9 of pregnancy, since, in this period, rabbit TBs begin to tap maternal 
blood vessels and gastrulation has already been concluded (Hoffman et al., 1999). On the other 
hand, day 21 of pregnancy was selected as it is a period in which fetal viability is critical, since a 
significant change in the uteroplacental blood flow takes place, being more abundant the irrigation 
of the placenta than what is in the uterus (Hafez & Tsutsumi, 1996). Furthermore, by that time of 
gestation, organogenesis is assumed to be achieved (Beaudoin et al., 2003). The main results of 
this first work evidenced that undernourished fetuses displayed reduction in their biometry, 
specifically a shorter occipito-nasal length respect well-nourished fetuses. Our results confirm the 
reliability of the occipito-nasal length as a valid measure to detect changes in fetal growth by 
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ultrasonography, as exposed by Kelly & Newnhamm (1989). Thus, undernourished fetuses 
denoted clear signs of hemodynamic alterations, as evidenced by lower end-diastolic velocities 
and significantly higher systolic peak and time-averaged mean velocities, which resulted in a 
trend for higher indexes of pulsatility and resistance at the UCA. These findings are important for 
characterizing the sequence of hemodynamic deterioration in the IUGR rabbit model and 
reinforce the UCA as an easy and reliable vessel to determine blood exchange (Acharya et al., 
2005). Furthermore, the low end-diastolic velocities observed in our trial are in line with the 
observation that in cases of placental insufficiency, end-diastolic velocities at the UCA decline 
(Baschat, 2011; Bansal et al., 2016). Moreover, in this part of the study we observed a significant 
reduction in the cerebroplacental ratio. This ratio quantifies the redistribution of the cardiac output 
by dividing Doppler index from cerebral and fetoplacental vascularity and may suggest an early 
stage of the sequence of “brain sparing effect”, although no direct changes at the MCA were 
observed. Our results support the use of this index and confirm that altered cerebroplacental ratio 
is indicative of adverse neonatal outcome, as observed in humans (DeVore, 2015; Ropacka-
Lesiak et al., 2015). The possible consequences of such redistribution in our model remain 
unclear. It has been proposed that brain sparing phenomenon is a “protective” effect to safeguard 
brain development and function (Torres-Rovira et al., 2013). However, IUGR newborns with signs 
of brain sparing showed worse neurodevelopmental and behavioural outcomes than IUGR infants 
without signs of this mechanism (Cohen et al., 2015). In rabbits, pups developed in an 
undernourished uterus showed altered eating, drinking and locomotor behaviors (Simitzis et al., 
2015), which ultimately could affect their growth performance in the farm. In our study, we 
corroborated that newborns developed in the harshest conditions were reduced in weight and 
size, clear signs of IUGR. Despite the restriction and the reduced phenotype of the offspring, 
mortality rate at birth was not increased. These results, along with the lack of significant changes 
in the weight of the mothers, reinforce the possible “conflict of interest” of the pregnant mother 
respect the growth of her offspring (Fowden & Moore, 2012). Thereby, the data obtained in the 
mortality rate demonstrates that the decision of the mother of not investing more resources to her 
litter was right despite its reduced morphometric outcome. 
As soon as we validated our animal model of IUGR and our level of restriction, in the second 
chapter, we studied whether SC could allivate the effects of MFR on placenta development, fetal 
growth and offspring outcome. We also deepen our knowledge in the IUGR pathogenesis by the 
study of blood flow changes determined by Doppler ultrasonography, the possible changes in the 
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development of fetal organs and the potential metabolic alterations (carbohydrates and lipids) 
induced by MFR/IUGR and/or SC administration. We decided to start the treatment with SC 
(Viagra®) on day 22, as we knew from the first chapter that the incidence of IUGR is increased 
due to the high requirements of the fetus for growth. Previous studies in pregnant women 
observed promising results, improving maternal and fetal blood flow velocimetry and fetal 
wellbeing (Lacassie et al., 2004; Lin et al.,2012; Panda et al., 2014; Sun et al., 2014). However, 
the study of the placenta was lacking.   
The results of this trial were in line with what we previously observed in the first chapter. As we 
expected, MFR resulted in offspring suffering from IUGR on day 28 of pregnancy and at birth, but 
did not result in increased mortality rates of the offspring. MFR significantly reduced all 
morphometric parameters compared to well-nourished fetuses/newborns (crown-rump length, 
biparietal and thoracic diameters). Furthermore, at day 28 of pregnancy, these fetuses displayed 
significant alterations in the proportion of their organs, which are clear signs of asymmetric IUGR 
(Anderson, 1972). Undernourished fetuses showed reductions in head and trunk weights, which 
were associated to reduced weights of the brain and liver. Thus, undernourished fetuses 
evidenced increased brain and BLR ratios. The increase in such ratios is signs of blood flow 
distribution towards the brain (Anderson, 1972; Mitchell, 2001; Marton et al., 2013). These 
findings support previous studies in which the raise of BLR was associated with undernutrition 
and dysmaturity conditions (Anderson 1972; Camm et al., 2010). Moreover, when we performed 
the Doppler examination we observed altered hemodynamics in the MCA of these fetuses, 
specifically, increased systolic peak and time-averaged mean velocities, important findings that 
we did not observe in the first study. The raise in the systolic peak, which indirectly affected time-
averaged mean velocity, has been reported in cases of fetal anemia (Mari, 2005), may be 
secondary to placental insufficiency. 
Nevertheless, when we studied the metabolic profile of these fetuses, we observed that despite 
the MFR, undernourished fetuses did not develop hypoglycemia (common feature in IUGR; 
Hawdon et al., 1993; Fafoula et al., 2006). In fact, their normoglycemia was associated with 
similar plasma concentrations of cholesterol and triglycerides respect well-nourished fetuses. 
These findings may be explained by two different hypotheses. Firstly, glucose and lipid 
transporters in the placenta could be more efficient exchanging these products, maybe in 
response to hormonal signals driven by the undernourished fetuses (Gaccioli et al., 2013). Other 
Chapter 4  Discussion 
121 
 
option may involve that the placenta could adapt its metabolic rate favoring allocation of 
resources to the fetus over its own necessities. In this regard, previous experiments based on 
genetic and dietary treatments have demonstrated that the placenta can adapt its phenotype and 
function according to maternal and fetal interests (Fowden et al., 2006; Sandovici et al., 2012; 
Sferruzzi-Perri et al., 2016). In fact, we found that MFR impaired placental structure phenotype 
(reduced length of the Db and Lz) and led to placental histopathological conditions (e.g. atrophy 
and fibrosis) without affecting placental weight mass. This last effect is important, as usually 
placenta weight positively correlates with growth parameters of the offspring (Soliman et al., 
2013). However, it has been demonstrated, in rats and sheep that an application of a 50% MFR 
results in heavier placentas (Heasman et al., 1998; Langley-Evans et al., 1996). This increment 
could be a compensatory mechanism of the placenta to alleviate nutritional deficits by expanding 
their surface area. Further stereological studies involving the determination of fetal capillary or 
maternal blood space volumes as well as diffusion capacity of the placenta are required. Finally, 
at the Doppler examination, we observed hemodynamic alterations in the placenta, specifically an 
increased systolic peak velocity at the UCA, as previously observed in the first study of this thesis 
and in mothers suffering from pregnancy complications (Landon et al., 1989; Dicker et al., 1990). 
Regarding the effectiveness of SC, we confirmed that the administration of this drug could 
alleviate states of placental dysfunction; as these placentas showed significant changes when 
compared with those in the restricted group. Placentas treated with SC evidenced higher values 
of Lz ratio, which may be indicative of a compensation of the Lz to support fetal growth. Thus, 
absence of fibrosis and increased numbers of dilated small capillaries, venules and arterioles 
were found in these treated placentas. These features observed in the Lz are in line with previous 
works in mice. In this sense, Luna et al. 2015 found slightly vasodilation at the Lz. At the Db, SC 
increased the thickness and significantly altered arterial sinuses (hyperplasia and hypertrophy), 
which could have improved maternal blood flow towards the placenta, thereby facilitating 
maternal blood flow supply to the fetus. In this regard, the myometrium and the decidua vessels 
express high levels of PDE-5 (Buhimschi et al., 2004; Coppage et al., 2005) and, in the case of 
the rabbit, the placenta has a high expression of NOS, especially NOS3 (Khan et al., 2012), 
which may facilitate SC function. Consequently, when we determined fetal growth, we observed 
that fetuses treated with SC significantly increased their size (higher crown-rump length and 
biparietal and thoracic diameters), but SC failed to improve fetal weight. Such findings were also 
observed at birth. The fact that SC could not improve fetal weight supports previous results 
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obtained in different rodent models (Ramesar et al., 2010; George et al., 2013; Motta et al., 
2015), but disagrees with the sheep model of undernutrition, in which fetal weight was increased 
by 14% (Satterfield et al., 2010). These differences may be related to the length of the treatment 
(87 days vs 5 to 7-10 days), but also may be associated to differences in resource allocation 
between monotocous and polytocous species (Fowden & Moore, 2012). 
Regarding fetal organs, SC could not revert the reductions in brain and liver weights associated 
to our model. However, SC significant increased the proportion of the liver respect the body 
weight of the fetus (liver ratio) compared to well- and under-nourished fetuses. Liver enlargement 
has been reported in rat fetuses exposed to SC (Pellicer et al., 2011). Thus, fetuses treated with 
SC evidenced hyperglycemic states compared to the other two groups, which may be associated 
to the increased liver proportion. Surprisingly, when we studied the hemodynamic changes, we 
observed that this therapy increased the resistance indices (IP and IR) at the MCA, as observed 
by Dastjerdi et al. (2012) in pregnant women, which may suggest certain grade of 
vasoconstriction, as low indices reflect redistribution of cardiac output to the brain (Mari et al., 
2007). The fact that SC can cross the placenta (Pellicer et al., 2011) and increase cGMP levels 
and cerebral blood flow (Zhang et al., 2002; Li et al., 2007) suggest us that the fetus may 
developed mechanisms to avoid excess of blood-flow supply in order to counteract possible 
adverse outcomes. Therefore, all these data should be taken with caution and further studies are 
required to corroborate the results in other time points of gestation as well as with other drug 
dosage. Moreover, elucidate whether the administration of this drug has postnatal consequences 
in the offspring health should be a main priority. Postnatal studies performed in mice exposed to 
SC in utero have observed that the offspring develops hypertension (increased systolic blood 
pressure) and reduced glucose sensitivity, suggesting metabolic alterations (Renshall, 2015). 
However, this last effect was only observed in female mice (Renshall, 2015). In contrast, SC can 
restore cognitive function but not motor activity in rats born from pre-eclamptic mothers (Cauli et 
al., 2010). Future works should determine such effects in our rabbit model. 
Finally, in the third chapter, we decided to explore other time windows of the rabbit gestation. We 
sought to determine the consequences of the 50% MFR during the preimplantational period (from 
day 0 to day 7 of the pregnancy) or throughout gestation (day 0 onwards). To have a global idea 
about the effects that MFR could generate in those periods of gestation, in this study, we 
evaluated all the “gestational compartments”, mother, placenta and fetus. Specifically, we 
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assessed maternal metabolism throughout gestation by determining possible changes in leptin, 
plasma carbohydrates and lipid metabolites. Alterations in fetal and placental morphometric 
parameters were determined on day 28 of pregnancy. Thus, we also performed histopathological 
evaluation and apoptosis quantification in placental tissue in order to unravel possible 
mechanisms involved in the pathogenesis of placenta insufficiency and IUGR.  
We observed that maternal body weight, plasma leptin concentrations and carbohydrates 
(glucose and fructosamine) were not affected by the MFR. Leptin is responsible for maintaining 
the metabolic state of the animal. This hormone can be considered as a good indicator of the 
metabolic status of the mother, as decreasing leptin concentrations may reflect a negative 
energetic balance (Menchetti et al., 2015b). The lack of changes observed in leptin, along with 
the maintained glucose and fructosamine profiles observed in both restricted groups may suggest 
that, despite the restriction, food supplied was enough to cover maternal requirements. Our 
results are supported by previous works from Matsuoka et al. (2009), who found similar blood 
glucose levels in pregnant rabbits exposed to MFR, and disagree with the findings of Menchetti et 
al. (2015b). Lastly, the normoleptinemia found in these animals also disagree with the results 
exposed by Menchetti et al. (2015b). These steady levels of leptin suggest us that females could 
have had a positive energetic balance despite the restriction or may involve an increased 
production of leptin by placental and/or fetal compartments (Jelks et al., 2009; Kirat et al., 2015). 
In this regard, pregnant rats exposed to a 50% MFR showed a markedly increased in the 
circulating levels of leptin compared to well-nourished dams and this was associated to an 
upregulation of placental leptin (Jelks et al., 2009). 
In this study, we also observed that MFR was associated with alterations in maternal lipid profile, 
specifically in increments in plasma cholesterol and LDL-c concentrations and reduced levels of 
HDL-c and triglycerides. Most of the differences were observed between day 7 to day 14 of 
pregnancy, important periods for embryonic differentiation, implantation and early placentation 
(Weisbroth et al., 1974; Fischer et al., 2012). As previously exposed in the introduction, the first 
third of the pregnancy is usually considered as an anabolic phase due to the low requirements for 
growth of the developing embryo (Lain & Catalano, 2007). The altered lipid profiles found in 
undernourished mothers, in a more severe grade when the restriction was maintained throughout 
gestation, may suggest a physiological response of the dam to enhance implantation and 
placental formation. However, the increment of plasma cholesterol and LDL-c could have had a 
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rebound effect on embryo-fetal development and placental homeostasis, affecting gene 
expression at the blastocyst stage (Tarrade et al., 2013) and may increasing free radicals by an 
excess of oxidative stress, which lastly could have disrupted the normal placentation (Chatzi et 
al., 2009). Future research should be focus in these findings and its consequences in embryo 
patterning and early placentation. 
In contrast, we have observed that plasma triglycerides were lower in the early stages of the 
pregnancy. This may suggest that the application of this level of MFR induced resource allocation 
strategies in the mothers to enhanced removal of triglycerides from circulation, increasing 
deposition of fat in maternal adipose tissue in the first third of gestation to support the exponential 
fetal growth in the last third of gestation and subsequent lactation (Chandi et al., 2015). The 
results of this chapter show that undernourished mothers do not invest more than necessary in 
their offspring growth, which could be a good maternal strategy for future generations and for 
their own energetic balances (Fowden & Moore, 2012).  
In line with previous studies of this thesis, we have observed that MFR disrupted fetal growth 
trajectory even when this feeding regimen was applied only during the preimplantation period. 
However, it was not associated to increased embryo-fetal mortality or altered implantation rates. 
Fetuses restricted during their whole period of gestation displayed significant reductions in size 
and weight. In contrast, those fetuses restricted only during the preimplantational period only 
evidenced reductions in their biometry (crown-rump length), as fetal weight was unchanged. 
These results support the idea that those mothers could have partially satisfied the requirements 
for growth of their offspring.  
The assessment of the different fetal organs evidenced that both MFR strategies generate 
changes in the organogenesis. Specifically, liver weight was significantly reduced in both 
restricted groups respect to the ad libitum fed group. However, what was even more surprising 
was that the exposure to MFR only during preimplantational period resulted in altered proportions 
of the brain mass respect body weight. In this sense, animals exposed to such challenge 
evidenced altered brain ratios but no differences were found in total brain mass versus well-
nourished fetuses, suggesting an enhanced and effective response of the fetus to prioritize brain 
development. However, BLR, indicative of asymmetric IUGR, was significantly higher in these 
animals; in line with the results observed in the fetuses developed in the harshest conditions 
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(throughout gestation). Future works should determine possible perinatal and postnatal brain 
abnormalities in these animals. Promising results may be obtained by magnetic resonance 
imaging (Simoes et al., 2015) or metabolomics (Simoes et al., 2016). 
Finally, the study of the placentas revealed that the weight of this organ was unchanged in the 
preimplantational group. However, when MFR was carried out during the whole period of 
gestation, a significant reduction in the weight of the organ was found. Such finding is important 
to be remarked, as in the previous study (results 3.2) we did not observe changes in placental 
weight when we challenged pregnant rabbits from day 9 of gestation. This difference obtained 
using similar level of MFR, but applied in different time windows of gestation, may reinforce the 
preimplantational period and early stages of placental formation as critical points for placental 
establishment. Thus, it may suggest that the mother can compensate the early nutritional deficits 
from day 8 onwards. Future works should be focus in these early stages of placentation. 
However, histopathological findings in placental tissue have revealed that labyrinth stromal 
collapse is a common feature when MFR is applied, even if it is applied only during the 
preimplantation period. Finally, we have observed that apoptosis is a common biological 
phenomenon in placenta tissue and may be associated to placental remodeling (Smith et al., 
1997) and degenerative mechanism of the placenta near term (Mossman, 1926). However, what 
we have demonstrated is that imbalanced diets in gestation can increase apoptosis, which lastly 
may reduced nutrient and gases exchange, resulting in placenta insufficiency and IUGR. Thus, 
our study sets the bases on placental apoptosis in the rabbit placenta at term and is in line with 
the range of apoptosis rate reported in previous studies of MFR (Belkacemi et al., 2009) and 
placental localization in mouse (Mu et al., 2002), showing higher rates of apoptosis in the decidua 
with respect to the other zones of the placenta.  
Overall, the data presented within this thesis suggest that MFR applied in different time windows 
of the rabbit gestation generate changes in maternal metabolism (associated to plasma lipids) 
without effect on maternal body weight. However, important changes in placental morphometry, 
function and homeostasis can occur even when MFR is applied only during preimplantational 
period, which may result in altered nutrient and oxygen transport to the fetus. Because of such 
impairments, fetal growth trajectory can be disrupted. However, these restrictions do not result in 
higher embryonic rate lost or higher intrauterine/early postnatal mortality rates of the offspring in 
any of the strategies employed. Nevertheless, the extent of the alterations observed in fetal and 
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neonatal morphometry will depend on the time of MFR application, being more severe when the 
MFR is carried out throughout gestation. These alterations are associated with the capacity of the 
mother to allocate her resources and the capability of the placenta to transfer them. Key organs 
such as brain and liver, which are critical for an adequate growth and health of the offspring can 
be altered. The insonation of the MCA has revealed that, in the rabbit model of undernutrition, the 
sequence of deterioration raises in the last third of gestation, as no direct effects in this vessel 
were observed on day 21 of gestation, but it did change on day 26 of gestation. This is in line with 
the idea that asymmetric IUGR fetuses are in a higher risk of suffering from brain damages as a 
consequence of the hypoxia and lack of nutrients. Consequently, the application of therapeutic 
interventions within this period of gestation could be beneficial to mitigate adverse cerebral and 
vascular outcomes. In this regard, the application of SC did not increase fetal or neonatal weight 
in our rabbit model of undernutrition. Thus, the administration of this drug, applied for the first time 
in a rabbit model, may imply alterations in brain networking formation, liver growth and 
hyperglycemic states in prenatal life that deserves further studies. However, SC counteracts 
reductions in perinatal body size and modifies placental growth and vascularization. Finally, 
taking into account all the data exposed in this thesis, the application of these feeding programs 
in rabbit farms should be done with caution. However, further research involving postnatal growth, 
meat characteristics and economic profitability of the farm are required. 
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Considering the experimental conditions of this research and based in the results obtained, the 
conclusions of this thesis are:  
1) Maternal food restriction by 50% of the pre-gestational ad libitum intake during the rabbit 
gestation results in placental insufficiency and IUGR at birth, validating the rabbit as a 
suitable model of IUGR by maternal undernutrition. Fetal ecography and Doppler 
ultrasonography are adequate non-invasive methods to detect early reductions in the fetal 
biometry and fetoplacental blood flow alterations. 
 
2) The protocols of maternal food restriction studied in this thesis do not affect maternal plasma 
leptin or glucidic metabolities, but alter maternal lipid metabolism during the periods of 
embryo development and early placental formation. Maternal food restriction induces 
histopathological changes in the placenta, which are mainly observed in the decidua and the 
labyrinth zone. Thereby, fetal growth trajectory is disrupted, impairing brain and liver 
development. 
 
3) Sildenafil Citrate alleviates states of placental dysfunction and improves body size without 
increasing body weight in the rabbit offspring. Thereby, the administration of this drug could 
partially counteract the adverse effects of maternal food restriction. However, this therapy 
may imply hyperglycemic states in the fetus as well as possible blood overflow in the brain. 
 
4) Maternal food restriction protocols should be applied with caution in livestock animals, since 
conceptus development can be disrupted and offspring growth at birth altered. These 
changes can affect postnatal growth and, therefore, modify the long-term productive goals. 
However, further studies addressing this issue are required.  
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 Considerando las condiciones experimentales de esta investigación y en base a los resultados 
obtenidos, las conclusiones de esta Tesis Doctoral son: 
 
1) La aplicación de una restricción alimentaria a conejas gestantes, basada en una reducción 
del 50% sobre el consumo de pienso ad libitum en estado no gestante, genera insuficiencia 
placentaria y crecimiento intrauterino retardado a nacimiento. La ecografía fetal y la técnica 
Doppler son métodos no invasivos adecuados para la detección temprana de cambios en la 
biometría fetal y alteraciones en la hemodinámica fetoplacentaria. 
 
2) Los protocolos de restricción alimentaria estudiados en la presente Tesis Doctoral no 
afectaron a las concentraciones plasmáticas de leptina ni el metabolismo glucídico materno. 
Sin embargo, sí modificaron al metabolismo lipídico en las primeras etapas embrionarias y 
de formación placentaria. La restricción alimentaria generó cambios histopatológicos en la 
placenta, principalmente en la zona de la decidua y del laberinto. Por consiguiente, el 
crecimiento fetal se vio alterado, así como el desarrollo del cerebro y del hígado. 
 
3) El Citrato de Sildenafilo puede contrarrestar estados de insuficiencia placentaria inducidos 
por restricción alimentaria gestacional y mejorar el tamaño de la descendencia sin llegar a 
provocar un aumento del peso de la misma. Sin embargo, esta terapia puede implicar 
estados hiperglucémicos en el feto, así como un posible aumento del flujo sanguíneo a nivel 
cerebral.  
 
4) Los protocolos de restricción alimentaria gestacional al 50% en hembras en producción se 
deben llevar a cabo con cierta cautela ya que inducen alteraciones en el desarrollo de la 
placenta, del feto y de los gazapos al nacimiento. Estos cambios podrían afectar el 
crecimiento postnatal y por tanto influir en los rendimientos productivos de la explotación a 
largo plazo, aunque más estudios son necesarios al respecto. 
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During my PhD I have chosen rabbits as the animal model not only to help me understand the 
pathogenesis of complicated pregnancies but also and more specifically, to determine the 
consequences of reduced maternal food intake and IUGR. Moreover, I have investigated the 
effects of a pharmacological therapy based on the administration of Sildenafil Citrate to 
counteract placental insufficiency and IUGR. 
  
Despite my short research career, I have also been involved in other projects, i.e. rabbit oocyte 
studies to knock out models in rodents. This particular project was conducted by the University of 
Cambridge, in Dr. Sferruzzi-Perri laboratory at the Centre for Trophoblast Research (CTR). Using 
genetic tools, we found that altering the expression of a growth gene (Igf2) in only the hormone-
producing part of the mouse placenta, altered placenta development and the mother´s ability to 
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My future career plan is to specialise in determining the specific and fascinating role of placental 
hormone when it comes to adapting maternal metabolism to favour nutrient allocation to fetal 
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Invited talks 
 
19–02–2015  “Sildenafil citrate modifies fetoplacental development in a rabbit model of 
intrauterine growth restriction”   
 
Centre for Trophoblast Research. Department of Physiology, Development and 
Neuroscience. University of Cambridge, UK 
 
Public Outreach 
 
1) XVI Semana de la Ciencia “Ven a manipular gametos y embriones a nuestro 
laboratorio” 
I was involved in a workshop organized to undergraduates about different laboratory 
techniques involving embryo recovery and physiology of the rabbit gestation. This workshop 
was hold in the Veterinary Faculty of the University Complutense of Madrid on the 25th of 
November 2016. 
 
2) López-Tello J, Arias-Álvarez M, Rebollar PG. (2016) Restricción alimentaria durante la 
gestación en conejas. ¿Existe un conflicto de intereses entre madre y feto? Boletín de 
cunicultura lagomorpha, (179), 14-19. (Publication) 
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2016  The Physiological Society UK 
 
2016 The International Society of Developmental Origins of Health and Disease 
 
 
Additional courses 
 
1) Radioactivity Substances: An introduction to Suitable and Safe Use Course. 
Department of Biochemistry, University of Cambridge, UK 2016. 
 
2) Placental Disease: Intrauterine growth restriction and Preeclampsia. Update in clinical 
management. Hospital Clinic Barcelona. Spain 2015. 
 
3) Diploma in Reproductive Biotechnology. Veterinary Faculty, Complutense University of 
Madrid. Spain 2015. 
 
4) Reproduction, Breeding and Nutrition in the Rabbit Production. Polytechnic University of 
Valencia. Spain 2014. 
 
Clinician experience & externships 
 
July-Sep 2014 Veterinary Volunteer at Lanta Animal Welfare. Koh Lanta. Thailand 
Main responsibilities included: soft tissues surgeries (reproductive, abdominal, 
head and neck), wound care and reconstruction, establishment of preventive and 
internal medicine protocols (dogs, cats, cattle, exotic animals). 
 
2011-2013 Murube y Barrero, Equine Veterinary Services. Madrid. Spain 
I was involved in the daily ambulatory practice, internal medicine, dental clinic, 
lameness, reproductive management (Breeding, AI, mare synchronization, 
foaling and neonatal emergencies). 
 
2009-2012 Galapavet, Small Animal Ambulatory. Madrid. Spain 
  As student, I participated in diagnostics, treatments and surgical support. 
 
2008-2011 ASAP mascotas. Madrid. Spain 
As student, I participated in the daily taskes of a small ambulatory clinic, 
veterinarian support and administrative help. 
 
 
 
 
  
 
  
 
